Search

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

A
Aarstøy H. - NT-PROBNP, AND NOT TF, FM, PAPP-A, MPO OR CD40 LIGAND, PREDICTS RECURRENT TROPONIN-T POSITIVE CARDIAC EVENTS FOLLOWING AN ACUTE MYOCARDIAL INFARCTION
Aaspollu A. - PLATELET AGGREGATION INHIBITING COMPONENTS FROM VIPERA LEBETINA SNAKE VENOM
Abbadessa V. - ENDOGENOUS THROMBIN POTENTIAL IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOSIS
Abbate R. - ROLE OF D-DIMER IN COMBINATION WITH F1+2, RVO AND THROMBOPHILIA IN THE RISK OF RECURRENCE OF PATIENTS WITH A FIRST VTE EPISODE AFTER OAT WITHDRAWA
  - CLINICAL DETERMINANTS OF PLATELET FUNCTION IN PATIENTS WITH CAD UNDERGOING CORONARY ANGIOGRAPHY AND TREATED BY DUAL ANTIPLATELET THERAPY
  - EFFECT OF REHABILITATION PROGRAM ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND INFLAMMATION IN PATIENTS UNDERGOING CARDIAC SURGERY
  - LOW RESPONSIVENESS TO CLOPIDOGREL AND STENT THROMBOSIS
  - CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND INFLAMMATION IN PATIENTS BEFORE AND AFTER CARDIAC SURGERY
  - QUALITY OF OAT AND VTE RECURRENCE
  - VITAMIN B6 AND FOLIC ACID ARE RISK FACTORS FOR RETINAL VEIN OCCLUSION INDEPENDENTLY OF HOMOCYSTEINE LEVELS
  - EFFICACY OF OMEGA-3 FATTY ACIDS IN LOWERING LIPOPROTEIN(A) LEVELS
  - LIPID, INFLAMMATORY AND HAEMORHEOLOGICAL PROFILES ARE SIGNIFICANTLY AFFECTED BY FARMED FISH EATING: AN INTERVENTION STUDY
  - GENETIC ANALYSIS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS-GAMMA (PPARG) PROMOTERS: ACUTE CORONARY SYNDROME PATIENTS VERSUS CONTROLS
  - GENETIC ANALYSIS OF 56 POLYMORPHISMS IN 18 GENES INVOLVED IN HOMOCYSTEINE METABOLISM IN PATIENTS WITH ABDOMINAL AORTIC ANEURYSM
  - ROLE OF INFLAMMATION IN MODULATING GRAFT TOLERANCE INDUCED BY MESENCHIMAL STEM CELLS
  - CHANGES OF INFLAMMATORY MARKERS DURING FOLLOW-UP OF PATIENTS WITH HEART FAILURE UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY
  - THROMBOPHILIA IS FREQUENT IN SUPERFICIAL VEIN THROMBOSIS AND IS ASSOCIATED WITH RECURRENCE
  - HOMOCYSTEINE AS INDICATOR OF OSTEOPOROSIS. THE INCHIANTI STUDY
  - MUTATION SCREENING ANALYSIS OF TGFBR1 GENE IN PATIENTS WITH MARFAN SYNDROME
  - ALTERED ULTRALARGE VON WILLEBRAND FACTOR LEVELS AND ADAMTS-13 ACTIVITY AFFECT RESIDUAL PLATELET REACTIVITY IN HIGH RISK VASCULAR PATIENTS ON DUAL ANTIPLATELET THERAPY
  - FISH INTAKE AND LPA 93CT POLYMORPHISM: GENE-ENVIRONMENT INTERACTION IN MODULATING LIPOPROTEIN (A) CONCENTRATIONS
  - HEMORHEOLOGICAL PROFILE IN RETINAL VEIN OCCLUSION
  - PHYSICAL ACTIVITY AND CARDIOVASCULAR RISK FACTORS IN A MIDDLE-AGED URBAN ITALIAN POPULATION
  - GENE EXPRESSION PROFILE INDUCED BY PHYSICAL EXERCISE IN RATS
  - ASSESSMENT OF CLOT LYSIS TIME TISSUE FACTOR-INDUCED BY EXOGENOUS T-PA IN HEALTHY SUBJECTS BY USING A MICROPLATE READER
  - ASSOCIATION BETWEEN METHYLENETETRAHYDROFOLATE REDUCTASE AND INFLAMMATORY MARKERS IN THE INCHIANTI STUDY
  - PHYSICAL ACTIVITY DURING LEISURE TIME AND PRIMARY PREVENTION OF CORONARY HEART DISEASE: AN UPDATED METAANALYSIS OF COHORT STUDIES
  - HOMOCYSTINURIA AND CARDIOVASCULAR MANIFESTATIONS: 5 ITALIAN CASES
  - RISK OF BLEEDING IN VERY OLD ATRIAL FIBRILLATION PATIENTS ON WARFARIN: RELATIONSHIP WITH AGEING AND CHADS2 SCORE
  - PROTEIN Z PLASMA LEVELS IN DIFFERENT LOCALIZATIONS OF ATHEROSCLEROTIC DISEASE
Abbate M. - ROSUVASTATIN EXERTS RENOPROTECTIVE EFFECTS IN STROKE-PRONE RATS BY MODULATING THE PLASMINOGEN/PLASMIN SYSTEM AND THE METALLOPROTEASES EXPRESSION
Abbate R. - ABDOMINAL AORTIC ANEURYSM AND CAROTID ARTERY DISEASE: GENE EXPRESSION PROFILING OF TWO ATHEROSCLEROTIC DISEASES
  - DO HIGH SENSITIVITY C-REACTIVE PROTEIN AND CYSTATIN-C SERUM LEVELS PREDICT TOTAL MORTALITY IN HEART FAILURE PATIENTS?
  - IN PERIODONTAL DISEASE THE INFLAMMATORY STATE IS ASSOCIATED WITH SUB-CLINICAL ATHEROSCLEROSIS
  - PLATELET FUNCTION EVALUATION BY USING A NEW POINT-OF-CARE SYSTEM AND PLATELET LIGHT-TRANSMISSION AGGREGATION IN A LARGE COHORT OF CORONARY ARTERY DISEASE PATIENTS
  - LIPOPROTEIN (A) AND VENOUS THROMBOEMBOLISM IN ADULTS: A META-ANALYSIS
  - ASSOCIATION OF THE G681A POLYMORPHISM OF CYP2C19 GENE WITH RESPONSE VARIABILITY TO DUAL ANTIPLATELET TREATMENT IN HIGH RISK VASCULAR DISEASE PATIENTS
  - HYPERVISCOSITY AS A POSSIBLE DETERMINANT OF INFARCT SIZE IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
  - MAXIMAL AND LATE ADP INDUCED PLATELET AGGREGATION IN CORONARY ARTERY DISEASE PATIENTS ON DUAL ANTIPLATELET THERAPY
  - POST-TREATMENT PLATELET FUNCTION PREDICTS MYOCARDIAL INJURY IN ACUTE MYOCARDIAL INFARCTION PATIENTS UNDERGOING PRIMARY PCI
  - B-GROUP VITAMINS' PROFILE AND OCCURRENCE OF CORONARY ARTERY DISEASE: A CASE-CONTROL STUDY
  - THE QUALITY OF ANTICOAGULATION ON FUNCTIONAL OUTCOME AND MORTALITY FOR TIA/STROKE IN ATRIAL FIBRILLATION PATIENTS
  - HIGH-THROUGHPUT MULTIPLEX SINGLE-NUCLEOTIDE POLYMORPHISM (SNP) ANALYSIS IN GENES INVOLVED IN METHIONINE METABOLISM
Abbene I. - PERIOPERATIVE BRIDGING THERAPY WITH LOW MOLECULAR WEIGH HEPARIN IN PATIENTS REQUIRING INTERRUPTION OF LONG-TERM ORAL ANTICOAGULANT THERAPY
  - THE PERSISTANCE OF RESIDUAL VEIN THROMBOSIS, AFTER AN EPISODE OF DEEP VEIN THROMBOSIS, AND THE RISK OF NEW OVERT CANCER AND CARDIOVASCULAR DISEASE
  - ENDOGENOUS THROMBIN POTENTIAL IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOSIS
Abd El-Kader A. - PROGNOSTIC SIGNIFICANCE OF MRD (MINIMAL RESIDUAL DISEASE) QUANTIFICATION BY PCR IN CHILDHOOD ACUTE LEUKEMIA
Abdel Gadir A.M. - HAEMOSTATIC AND CYTOKINE CHANGES IN GESTATIONAL AND PREGESTATIONAL DIABETES MELLITUS
Abdelnoor M. - PLASMINOGEN ACTIVATOR INHIBITOR-1 ACTIVITY PREDICTS RHYTHM OUTCOME AFTER ELECTRICAL CARDIOVERSION FOR ATRIAL FIBRILLATION
Abdelrahim M. - IMPACT OF TISSUE FACTOR-BEARING MICROPARTICLES DERIVED FROM TUMOR CELLS ON COAGULATION ACTIVATION
Abdihakim A. - HEMORHEOLOGICAL PROFILE IN RETINAL VEIN OCCLUSION
Abdollahi M. - THE PROTECTIVE EFFECT OF FXIII VAL34LEU POLYMORPHISM AGAINST VENOUS THROMBOSIS IN IRANIAN PATIENTS
Abdullahi A. - THROMBOPHILIA IS FREQUENT IN SUPERFICIAL VEIN THROMBOSIS AND IS ASSOCIATED WITH RECURRENCE
Abdullahi Said A. - CHANGES OF INFLAMMATORY MARKERS DURING FOLLOW-UP OF PATIENTS WITH HEART FAILURE UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY
  - THE QUALITY OF ANTICOAGULATION ON FUNCTIONAL OUTCOME AND MORTALITY FOR TIA/STROKE IN ATRIAL FIBRILLATION PATIENTS
  - RISK OF BLEEDING IN VERY OLD ATRIAL FIBRILLATION PATIENTS ON WARFARIN: RELATIONSHIP WITH AGEING AND CHADS2 SCORE
Abe Y. - ELEVATED D-DIMER LEVELS IN PATIENTS WITH DEEP VEIN THROMBOSIS
  - ADAMTS13 RELATED MARKERS IN PLASMA FROM PATIENTS WITH TTP
  - PHARMACOLOGICAL CHARACTERIZATION OF AN ORAL DIRECT THROMBIN INHIBITOR, MCC-977: HIGH THROMBIN SPECIFICITY AND LOW HEMORRHAGIC PROFILE
Abe K. - PLATELET VOLUME IN CORD BLOOD
Abedini M. - EVALUATION FOR HYPERCOAGULOPATHY IN THALASSEMIA MAJOR PATIENTS IN ISFAHAN
Åberg M. - ANTIAPOPTOTIC SIGNALING BY TF/FVIIA IS INHIBITED BY SIMVASTATIN
Abgrall J. - DETECTING PROTHROMBOTIC STATES USING A THROMBIN GENERATION TEST IN RELATIVES OF PATIENTS WITH VENOUS THROMBOEMBOLISM AND FACTOR V LEIDEN
Abid-Hussein M.N. - INHIBITION OF MICROPARTICLE RELEASE TRIGGERS ENDOTHELIAL APOPTOSIS
  - SIMVASTATIN-INDUCED ENDOTHELIAL CELL DETACHMENT AND MICROPARTICLE RELEASE ARE PRENYLATION DEPENDENT
Abinet I. - PROPOSITION FOR A MULTI-STEP MUTATION DETECTION IN HAEMOPHILIA A
Abo A. - RNAPC2, A NOVEL INHIBITOR OF TISSUE FACTOR/FACTOR VIIA COMPLEX, SUPPRESSES LIVER AND LUNG METASTASES IN MOUSE MODELS OF COLORECTAL CANCER
  - RNAPC2, A NOVEL INHIBITOR OF TISSUE FACTOR/FACTOR VIIA COMPLEX, SYNERGIZES WITH 5-FU OR BEVACIZUMAB IN A MOUSE MODEL OF COLORECTAL CANCER
Aboud M. - FIBRIN GENERATION IS NOT SUPPRESSED IN PATIENTS WARFARINISED FOR VENOUS THROMBOEMBOLISM (VTE)
  - A COMPARATIVE STUDY OF LOW MOLECULAR WEIGHT HEPARIN (LMWH) MONITORING BY ANTI-XA LEVELS, OVERALL HAEMOSTASIS POTENTIAL (OHP) AND CALIBRATED AUTOMATED THROMBOGRAM (CAT) ASSAYS
Aboulfatova K. - HUMAN VH1-69 GERMLINE GENE ENCODED ANTI-SPACER DOMAIN ANTIBODIES THAT DEVELOP IN PATIENTS WITH ACQUIRED TTP INTERFERE WITH THE BINDING OF ADAMTS13 TO VWF
Aboulghar M. - THROMBOPHILIA & RECURRENT FETAL LOSS: SHOULD WE SCREEN BOTH PARENTS ?
Abrahams J.M. - THROMBIN PROMOTES ANOMALOUS DIFFERENTIATION OF VASCULAR PROGENITOR CELLS DURING NEOINTIMAL HYPERPLASIA AFTER WIRE-INDUCED INJURY
  - NK CELL AND MACROPHAGE INFILTRATION INTO ORGAN XENOGRAFTS IS DEPENDENT ON THROMBIN-MEDIATED PRODUCTION OF MONOCYTE CHEMOTACTIC PROTEIN-1(MCP-1) THROUGH PAR-1
  - NEOINTIMAL CELLS IN WIRE-INJURED ARTERIES HAVE A MIXED ENDOTHELIAL CELL (EC)/VASCULAR SMOOTH MUSCLE CELL (VSMC) PHENOTYPE WHICH IS THROMBIN-DEPENDENT
Abreu Lima J. - SCREENING FOR THROMBOPHILIA: RETROSPECTIVE STUDY IN WOMEN WITH GESTACIONAL VASCULAR COMPLICATIONS
Abshire T.C. - U.S. INHIBITOR PILOT PROJECT: STUDY DESIGN AND METHODS VALIDATION
Abu-Ghoush M.W.H. - INHERITED BLEEDING DISORDERS- A 14 YEAR RETROSPECTIVE STUDY
Achard V. - DISRUPTION OF PAI-1 CIRCADIAN RHYTHM IN OBESE SUBJECTS MAY EXPLAIN A CHANGE IN THE TIME OF ONSET OF MYOCARDIAL INFARCTION
Achtergael W. - DIAGNOSTIC ACCURACY OF THE TRIAGE D-DIMER TEST FOR EXCLUSION OF VENOUS THROMBOEMBOLISM IN OUTPATIENTS
Ackerman P. - GENERIC VERSIONS OF BRANDED LOW MOLECULAR WEIGHT HEPARINS CAN BE DIFFERENTIATED IN BIOLOGIC AND PHARMACOLOGIC ASSAYS
Adam F. - PAR4 INDUCES FULL PLATELET SPREADING ON A FIBRINOGEN MATRIX: INVOLVEMENT OF ERK2 AND P38 AND CA2+ MOBILIZATION
  - INVOLVEMENT OF THE MAP KINASE JNK1 IN THROMBUS FORMATION
Adam M. - COMPARISON OF A HEPARIN-PLATELET FACTOR 4 (PF4)-ELISA FOR IGG, IGM AND IGA AND THE HEPARIN-INDUCED PLATELET ACTIVATION ASSAY (HIPA) WITH A HEPARIN-PF4-ELISA FOR IGG
  - ASSAY DEVELOPMENT FOR PLASMA FACTOR VIIA-ANTITHROMBIN COMPLEX (FVIIA-AT)
Adam Z. - LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Adam M. - ANTITHROMBIN (AT) COMPLEX FORMATION IN BEAGLE DOGS AFTER ADMINISTRATION OF A PHARMACOLOGICAL DOSE OF HUMAN RECOMBINANT FACTOR VIIA (RFVIIA)
  - DECREASE FACTOR VIIA/ANTITHROMBIN COMPLEXES IN PATIENTS WITH VENOUS THROMBOEMBOLISM: A NEW INSIGHT IN THE PATHOGENETIC MECHANISM
Adamczuk Y. - THROMBOPHILIA IN HIV-INFECTED PATIENTS WITH OSTEONECROSIS: IS THERE A REAL CONNECTION? THE FIRST CASE-CONTROL STUDY
Adamczuk Y.P. - CORRELATION BETWEEN DIFFERENT FIBRINOLYTIC TESTS IN PATIENTS WITH OBSTETRIC COMPLICATIONS
Adamopoulos A. - DOES ADMINISTRATION OF LANSOPRAZOLE AFFECT ASA ANTIPLATELET FUNCTION IN HIGH RISK CARDIOVASCULAR PATIENTS? PRELIMINARY RESULTS
Adams B. - DETERMINATION OF THE OESTROGEN RESPONSIVENESS OF A POLYMORPHIC ELEMENT IN THE HUMAN FACTOR IX GENE PROMOTER
Adams J. - CERTIFY, A PHASE III STUDY COMPARING CERTOPARIN WITH UNFRACTIONATED HEPARIN IN ELDERLY, ACUTELY ILL MEDICAL PATIENTS
Adams M. - THE SAFETY OF ANTICOAGULANTS IN PEDIATRIC ARTERIAL ISCHEMIC STROKE: PRELIMINARY RESULTS
Adamson U. - FIBRIN GEL POROSITY RELATES TO GLYCOSYLATED HAEMOGLOBIN IN PATIENTS WITH TYPE 1 DIABETES
Adamson P.J. - MULTIPLE SITES OF FXIIIA ARE INVOLVED IN THE BINDING INTERACTION TO THE ALPHA CHAIN OF FIBRINOGEN
  - PROTEOLYTIC CLEAVAGE OF ACTIVATED COAGULATION FACTOR XIII BY PLASMIN: NOVEL MECHANISM OF FACTOR XIII REGULATION?
Adamson U. - FIBRIN GEL POROSITY: COMPARISON OF TWO LABORATORY ASSAYS
Adamson P.J. - THE LOCALISATION OF A NOVEL FACTOR XIIIB BINDING SITE ON THE ALPHA CHAIN OF FIBRINOGEN AND ITS ROLE IN FXIII DISSOCIATION
  - IDENTIFICATION OF PROTEOLYTIC CLEAVAGE
Ádány R. - MODULATION OF THE RISK OF CORONARY ARTERY DISEASE BY THE INTERACTION BETWEEN FACTOR XIII SUBUNIT A VAL34LEU POLYMORPHISM AND FIBRINOGEN CONCENTRATION IN THE HUNGARIAN POPULATION
  - FACTOR XIII VAL34LEU VARIANT PROTECTS AGAINST CORONARY ARTERY DISEASE: A META-ANALYSIS
Adelmeijer J. - GLYCOPROTEIN IB-ALPHA CONTRIBUTES TO TISSUE FACTOR-INDEPENDENT THROMBIN GENERATION BY RECOMBINANT FACTOR VIIA ON THE ACTIVATED PLATELET SURFACE
Adida K. - IMPACT OF RISK FACTORS ASSOCIATED WITH VENOUS THROMBOSIS IN CYPROTERONE ACETATE AND ETHYNIL-ESTRADIOL USERS OR OTHER ORAL CONTRACEPTIVES USERS AND POSSIBLY PREVENTABLE CASES
Adinolfi E. - RELEASE OF TISSUE FACTOR-BEARING MICROPARTICLES BY HUMAN DENDRITIC CELLS INDUCED BY STIMULATION OF MEMBRANE P2X7 RECEPTORS
Aditya M. - NONINVASIVELY MEASURED AORTIC PULSE WAVE VELOCITY FOR DETECTION OF OBSTRUCTIVE CORONARY ARTERY DISEASE
Adler G. - THE ORAL DIRECT THROMBIN INHIBITOR AZD0837 REDUCES THROMBUS FORMATION IN A RAT MODEL
Adraktas T. - SAFETY AND EFFICACY OF TINZAPARIN ADMINISTRATION DURING PREGNANCY
Afrabiasi A. - GENETIC CHARACTERIZATION OF PATIENTS WITH BERNARD-SOULIER SYNDROME AND THEIR RELATIVES FROM SOUTHERN IRAN
Afrasiabi A. - KINETICS STUDIES OF A NATURALLY OCCURRING MUTATION ON FACTOR X (FX) GENE (G222D)
  - FACTOR XI DEFICIENCY IN SOUTHERN IRAN AND REVIEW OF LITERATURE
  - PLATELET ADAMTS13 AND IN VITRO EXPRESSION STUDY OF A PATIENT AFFECTED BY CONGENITAL TTP
  - PHENOTYPIC ANALYSIS OF THREE MUTATIONS CAUSING GLANZMANN THROMBASTHENIA
  - DETERMINATION OF PROTEIN C LEVEL IN NEONATES WITH SEPSIS LIKE ILLNESS
Afrasiabi R. - INFLUENCE OF INHERITED THROMBOPHILIA WITH RECURRENT PREGNANCY LOSS
Afshar H. - TIME COURSE OF COAGULATION FACTORS IN OVERT DISSEMINATED INTRAVASCULAR COAGULATION: A CASE STUDY
Aganezova N.V. - PREVALENCE OF HYPERHOMOCYSTEINEMIA IN WOMEN WITH PREMENSTRUAL SYNDROME AND EFFECT OF ORAL AND VAGINAL DELIVERY OF ETHINYL ESTRADIOL AND DEZOGESTREL ON HOMOCYSTEINE LEVELS
Ageenkova E.V. - LEVEL OF PLASMA GLYCOCALICIN IN CHILDREN WITH THROMBOCYTOPENIA
  - IDIOPATHIC THROMBOCYTOPENIC PURPURA AND OPPORTUNISTIC INFECTIONS IN CHILDREN
  - MASSIVE BLEEDINGS IN GIRLS DURING AND AFTER TERATOMAS EXCISION
Agenent W. - ANALYSING PLATELET FUNCTION FOR FUNCTIONAL GENOMIC STUDIES
Ageno W. - A MULTICENTER STUDY ON EARLY HEMORRHAGIC TRANSFORMATION IN ISCHEMIC STROKE: PRELIMINARY RESULTS
  - METABOLIC SYNDROME AND HYPERHOMOCYSTEINEMIA IN PATIENTS WITH DEEP VEIN THROMBOSIS: A CASE-CONTROL STUDY
  - ISOLATED DISTAL DEEP VEIN THROMBOSIS (ID-DVT) IN THE MASTER MULTICENTER ITALIAN REGISTRY
  - INHERITED THROMBOPHILIC ABNORMALITIES AND RISK OF PORTAL VEIN THROMBOSIS: A META-ANALYSIS
  - PREVENTION OF RECURRENT THROMBOEMBOLISM BY ADJUSTING THE DURATION OF ANTICOAGULATION ACCORDING TO RESIDUAL VEIN THROMBOSIS. A RANDOMIZED STUDY
  - EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH INR VALUES OF MORE THAN 10.0: RESULTS OF A PROSPECTIVE COHORT STUDY
  - INDIVIDUAL AND CLINICAL PREDICTORS OF THE TIMING OF DIAGNOSIS OF VENOUS THROMBOEMBOLISM: RESULTS FROM THE MASTER REGISTRY
  - PREVALENCE OF UNPROVOKED VENOUS THROMBOEMBOLISM AND OF TRANSIENT AND PERMANENT RISK FACTORS IN DIFFERENT AGE GROUPS: RESULTS OF THE MASTER REGISTRY
  - CARDIOVASCULAR RISK FACTORS AND VENOUS THROMBOEMBOLISM: A META-ANALYSIS
  - LATE BREAKING CLINICAL TRIAL: RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN TOTAL KNEE REPLACEMENT SURGERY: RESULTS OF THE RECORD 3 STUDY - LATE BREAKING
  - SPIRAL COMPUTED TOMOGRAPHY IN THE EVALUATION OF THE RESOLUTION OF PULMONARY EMBOLISM AFTER A STANDARD COURSE OF ANTICOAGULATION
  - EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH ELEVATED INR VALUES: RESULTS OF RANDOMIZED TRIAL EXAMINING CLINICAL OUTCOMES
  - SUBCLINICAL HYPOTHYROIDISM AND DEEP VENOUS THROMBOSIS. A PILOT CROSS-SECTIONAL STUDY
  - CLINICAL CHARACTERISTICS OF CANCER ASSOCIATED ACUTE VENOUS THROMBOEMBOLISM: FINDINGS FROM THE MASTER REGISTRY
  - SHOULD COMMON INERITED THROMBOPHILIC ABNORMALITIES BE TESTED IN CANCER PATIENT WITH CENTRAL VENOUS CATHETER?
  - DELAY IN STARTING ORAL ANTICOAGULATION IN PATIENTS WITH ACUTE VENOUS THROMBOEMBOLISM (VTE): ANALYSIS FROM THE MASTER REGISTRY
  - HELICAL COMPUTED TOMOGRAPHY TO ASSESS RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS WITH ACUTE PULMONARY EMBOLISM
  - BRAIN NATRIURETIC PEPTIDE AS A PRECLINICAL MARKER OF CHRONIC PULMONARY HYPERTENSION IN PATIENTS WITH PULMONARY EMBOLISM
Agerkvist I. - A NOVEL RECOMBINANT B-DOMAIN-DELETED FACTOR VIII EXPRESSED IN A HUMAN CELL LINE
Aggio M. - THROMBOPHILIA AND ISCHEMIC STROKE: A RETROSPECTIVE STUDY
Aghighi S. - THROMBIN GENERATION TEST (TGT) AND ROTATIONAL THROMBOELASTOGRAPHY (ROTEM) AND ITS USE IN ASSESSING SEVERE HAEMOPHILIA A PHENOTYPE
Aghili M. - THE CLINICAL RESULTS OF P32 RADIOSYNOVECTOMY IN HEMOPHILIC PATIENTS WITH CHRONIC SYNOVITIS
Agnelli G. - INDIVIDUAL AND CLINICAL PREDICTORS OF THE TIMING OF DIAGNOSIS OF VENOUS THROMBOEMBOLISM: RESULTS FROM THE MASTER REGISTRY
  - ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS C IN HEMOPHILIA PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS
  - EFFECT OF BLOOD SALVAGE AND RE-INFUSION ON VTE COMPLICATIONS IN PATIENTS UNDERGOING ELECTIVE MAJOR ORTHOPEDIC SURGERY
  - PREVENTION OF RECURRENT THROMBOEMBOLISM BY ADJUSTING THE DURATION OF ANTICOAGULATION ACCORDING TO RESIDUAL VEIN THROMBOSIS. A RANDOMIZED STUDY
  - TREATMENT OF PROXIMAL DEEP VEIN THROMBOSIS (DVT): RIVAROXABAN ONCE OR TWICE DAILY HAD SIMILAR EFFICACY AND SAFETY TO STANDARD THERAPY IN PHASE II STUDIES
  - PREVALENCE OF UNPROVOKED VENOUS THROMBOEMBOLISM AND OF TRANSIENT AND PERMANENT RISK FACTORS IN DIFFERENT AGE GROUPS: RESULTS OF THE MASTER REGISTRY
  - SOCIAL COSTS OF ANTICOAGULANT TREATMENT FOR ATRIAL FIBRILLATION
  - RANDOMISED, OPEN, PROSPECTIVE, MULTICENTER PILOT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ACTIVATED RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN ACUTE INTRACEREBRAL HAEMORRHAGE IN PATIENTS TREATED WITH ORAL ANTICOAGULANT OR ANTIPLATELET AGENTS
  - A MULTICENTER STUDY ON EARLY HEMORRHAGIC TRANSFORMATION IN ISCHEMIC STROKE: PRELIMINARY RESULTS
  - EFFECT OF BOLUS TENECTEPLASE (TNK) ON RIGHT VENTRICULAR DYSFUNCTION IN NORMOTENSIVE PATIENTS WITH PULMONARY EMBOLISM: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
  - ISOLATED DISTAL DEEP VEIN THROMBOSIS (ID-DVT) IN THE MASTER MULTICENTER ITALIAN REGISTRY
  - HAEMOPHILIA MANAGEMENT THROUGH AN INTER-REGIONAL NETWORK IN MIDDLE ITALY
  - EDHIT: EVALUATION OF DERMATAN SULPHATE IN PREVENTION AND TREATMENT OF HEPARIN INDUCED THROMBOCYTOPENIA
  - LOW-DOSE ASPIRIN FOR SECONDARY PROPHYLAXIS OF VEIN THROMBOSIS (THE ASPIRE STUDY) BASELINE CHARACTERISTICS AND EVENT RATES FROM THE FIRST 380 PATIENTS
  - OPTIMAL DURATION OF ANTICOAGULANT TREATMENT IN PATIENTS WITH VENOUS THROMBOEMBOLISM
  - PHARMACOKINETICS OF THE REFORMULATED B-DOMAIN DELETED RECOMBINANT FACTOR VIII (BDD-RFVIII) CONCENTRATE USING CHROMOGENIC AND ONE-STAGE ASSAYS WITH POOLED NORMAL PLASMA (PNP) AND REFACTO LABORATORY STANDARD (RLS)
  - CLINICAL CHARACTERISTICS OF CANCER ASSOCIATED ACUTE VENOUS THROMBOEMBOLISM: FINDINGS FROM THE MASTER REGISTRY
  - PROGNOSTIC VALUE OF TROPONINS IN ACUTE PULMONARY EMBOLISM: A META-ANALYSIS
  - HELICAL COMPUTED TOMOGRAPHY TO ASSESS RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS WITH ACUTE PULMONARY EMBOLISM
  - DELAY IN STARTING ORAL ANTICOAGULATION IN PATIENTS WITH ACUTE VENOUS THROMBOEMBOLISM (VTE): ANALYSIS FROM THE MASTER REGISTRY
Agniullin J.V. - EXPERIMENTAL MODEL OF THROMBOSIS IN RABBIT'S MARGINAL EAR VEIN
  - SUPERFICIAL THROMBOSIS (RATS AND RABBITS) AND ITS TREATMENT WITH THROMBOLYTIC PREPARATION LONGOLYTIN
Ågren A. - LABORATORY EVIDENCE OF HYPERFIBRINOLYSIS IN ASSOCIATION WITH LOW PAI-1 ACTIVITY
Aguado E. - ROLES OF THE C-TERMINAL TYROSINE RESIDUES OF LAT IN GPVI-INDUCED PLATELET ACTIVATION; INSIGHT INTO THE MECHANISM OF PLC GAMMA2 ACTIVATION
Aguiar A. - USE OF RFVIIA IN ELECTIVE SURGERY IN CASES WITH CONGENITAL COAGULOPATHIES AND INHIBITORS
Aguilar G. - RNAPC2, A NOVEL INHIBITOR OF TISSUE FACTOR/FACTOR VIIA COMPLEX, SUPPRESSES LIVER AND LUNG METASTASES IN MOUSE MODELS OF COLORECTAL CANCER
  - RNAPC2, A NOVEL INHIBITOR OF TISSUE FACTOR/FACTOR VIIA COMPLEX, SYNERGIZES WITH 5-FU OR BEVACIZUMAB IN A MOUSE MODEL OF COLORECTAL CANCER
Aguilar C. - CLINICAL EVALUATION OF A NEW QUANTITATIVE HIGHLY SENSITIVE D-DIMER ASSAY FOR EXCLUSION OF DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM
Agustsdottir M. - PREDICTION OF PRIMARY HEMOSTATIC DEFECT TYPE AND SEVERITY WITH THE PFA-100 CLOSURE TIME
Aguzzi G. - SOCIAL COSTS OF ANTICOAGULANT TREATMENT FOR ATRIAL FIBRILLATION
Ahamed J. - THE TISSUE FACTOR CYTOPLASMIC DOMAIN REGULATES PROCOAGULANT RESPONSES IN MACROPHAGES
Aharon A. - MICROPARTICLES' INDUCE PRO-COAGULANT AND APOPTOTIC EFFECTS ON ENDOTHELIAL CELLS
  - THE ROLE OF MICROPARTICLES IN GESTATIONAL VASCULAR COMPLICATIONS
Ahl S. - MONOCLONAL ANTIBODIES THAT MIMIC ANTIBODIES FOUND IN PATIENTS WITH DRUG (QUININE(QN))-INDUCED IMMUNE THROMBOCYTOPENIA (DITP): IMPLICATIONS FOR THE PATHOGENESIS OF DITP
Ahluwalia J. - INVESTIGATION OF THROMBOPHILIA DURING PREGNANCY AND PUERPERIUM: A STUDY FROM NORTH INDIA
Ahmad R.U. - PHARMACOKINETICS (PK) OF RVWF IN DOGS AND MICE WITH SEVERE VWD
Ahmad S. - MODULATION OF HEPARIN-PF4 ANTIBODY-MEDIATED PLATELET ACTIVATION BY A NOVEL GPIIB/IIIA RECEPTOR ANTAGONIST: IMPLICATIONS IN THE MANAGEMENT OF HIT
Ahmadinejad M. - HIGH PREVALENCE OF ELEVATED FACTOR VIII IN IRANIAN PATIENT WITH IDIOPATHIC VENOUS THROMBOEMBOLISM
  - HEREDITARY THROMBOPHILIC DEFECTS IN IRANIAN PATIENTS WITH CEREBRO VASCULAR ACCIDENT
  - HEREDITARY DEFICIENCIES OF ANTITHROMBIN, PROTEIN S, AND THE PROTEIN C PATHWAY IN IRANIAN DVT PATIENTS
Ahmady Negad M. - THROMBOTIC EVENTS IN PATIENTS WITH ELEVATED FVIII LEVEL
Ahnadi C.E. - EVALUATION OF THE ANTICOAGULANTS EDTA CONTAINING DISODIUM DIAZOLIDYL UREA TO PREVENT UNSOLICITED PLATELET ACTIVATION
Ahrens I. - MECHANISM OF PARADOXICAL PLATELET ACTIVATION INDUCED BY GPIIB/IIIA ANTAGONISTS
  - EVIDENCE FOR AN ALTERNATIVE REGULATION OF THE ACTIVITY OF THE BETA3-INTEGRIN ALPHAVBETA3 IN THE ABSENCE OF THE HIGHLY CONSERVED ALPHA-SUBUNIT GFFKR MOTIF
Aiach M. - EVIDENCE OF PROTEIN C (PC) GLA DOMAIN AMINO ACIDS CRUCIAL FOR INTERACTION WITH PROTEIN S (PS)
  - AN ABNORMAL MRNA SPLICING IS ASSOCIATED WITH THE A3 HAPLOTYPE OF THE EPCR GENE PROCR: A POSSIBLE NEW CONTRIBUTOR TO PLASMA SOLUBLE EPCR LEVELS
  - RECOMBINATION IN ENDOTHELIAL CELL PROTEIN C RECEPTOR GENE PROCR. INFERENCE FOR THROMBOPHILIC PATIENTS SCREENING
  - COMPARISON OF ENDOTHELIAL CELL PROTEIN C RECEPTOR (EPCR) MRNA FORMS IN MONOCYTES AND HUVEC
  - THE RGDS SEQUENCE OF THE ANTICOAGULANT PROTEIN C (PC) CONTRIBUTES TO ITS ENDOTHELIAL CELL RECEPTOR (EPCR) BINDING
  - BONE MARROW-DERIVED MONONUCLEAR CELL THERAPY INDUCES DISTAL ANGIOGENESIS AFTER LOCAL INJECTION IN CRITICAL LEG ISCHEMIA
  - THROMBIN ADSORBED TO A FIBRIN CLOT CONFERS ANGIOGENIC AND HEMOSTATIC PROPERTIES ON ENDOTHELIAL PROGENITOR CELLS
  - THE ABCB1 (MDR1) C3435T POLYMORPHISM DOES NOT INFLUENCE PHARMACODYNAMIC RESPONSE TO CLOPIDOGREL IN HEALTHY SUBJECTS
  - ALL PROTEIN S (PS) EPIDERMAL GROWTH FACTOR LIKE DOMAINS (EGFS) SIGNIFICANTLY PARTICIPATE TO ACTIVATED PROTEIN C (APC) COFACTOR ACTIVITY
Aillaud M. - CYP 2C19*2 AND MDR1+3435C ALLELES CONTRIBUTE TO LOW RESPONSE TO CLOPIDOGREL IN ACUTE CORONARY SYNDROME
Aillaud M.F. - RISK OF A FIRST VENOUS OR ARTERIAL EVENT IN CARRIERS OF A FAMILIAL THROMBOPHILIC DEFECT
Aird W. - VASCULAR BED-SPECIFIC THROMBOSIS
Aisina R.B. - MODULATION OF STAPHYLOKINASE-DEPENDENT PLASMINOGEN ACTIVATION BY OMEGA-AMINE ACIDS
  - INHIBITION OF PLASMINOGEN/PLASMINOGEN ACTIVATOR SYSTEM BY ANGIOSTATIN-LIKE PLASMINOGEN FRAGMENTS IS INVOLVED IN MECHANISM OF ANTIANGIOGENESIS
  - FIBRINOLYTIC SYSTEM COMPONENTS IN RABBIT TEARS AFTER CHEMICAL BURN OF CORNEA
Aït Chafa-Tadlaoui D. - HEMOSTASIS AND PREGNANCY: PRELIMINARY STUDY
  - NORMAL VALUES IN PERINATAL AND PEDIATRIC HEMOSTASIS IN ALGIERS
Aizawa Y. - CHARACTERISTIC FEATURES OF SOLUBLE FIBRIN (SF) AND SOLUBLE FIBRIN MONOMER COMPLEX (FMC) AS MEASURED BY IMMUNOASSAYS WITH IATRO SF AND AUTO LIAFM, RESPECTIVELY
  - PREVALENCE OF DEEP VENOUS THROMBOSIS IN A YEAR AFTER THE MID NIIGATA PREFECTURE EARTHQUAKE
Ajjan R. - RECOMBINANT BBETA-LYS448 IS ASSOCIATED WITH SIGNIFICANT CHANGES IN FIBRIN STRUCTURE AND CLOT RIGIDITY
Ajzenberg N. - INVOLVEMENT OF THE MAP KINASE JNK1 IN THROMBUS FORMATION
  - MONOCYTES DOWN-REGULATE INITIAL PHASE OF COLLAGEN-INDUCED PLATELET ACTIVATION
  - A ROLE FOR PLATELET ACTIVATION IN LACUNAR STROKE?
  - SCREENING FOR THROMBOPHILIA IN A RETROSPECTIVE STUDY OF 320 WOMEN WITH PREGNANCY COMPLICATIONS
Ajzner E. - GENERATION AND EXPRESSION OF RECOMBINANT FACTOR XIII-B MUTANTS
Akahane K. - EXTRACTS OF AN EDIBLE MUSHROOM WITH ANTITHROMBIN III-INDEPENDENT ANTICOAGULANT ACTIVITY
Akar N. - SOLUBLE ENDOTHELIAL PROTEIN C RECEPTOR AND CYTOKINE LEVELS IN TURKISH PEDIATRIC STROKE PATIENTS
Akarsu S. - INTRACRANIAL THROMBOSIS COMPLICATING THE MANAGEMENT OF HEMOPHILIC ARTHROPATHY: ANTICOAGULANT TREATMENT IN A CASE WITH HEMOPHILIA B
  - USAGE OF FACTOR VIIA IN A CASE OF HEMORRHAGIC CYSTITIS DEVELOPED SECONDARY TO CHEMOTHERAPY
Akbalik M. - CEREBRAL THROMBOSIS ASSOCIATED WITH HETEROZYGOUS FV LEIDEN MUTATION AND HIGH LIPOPROTEIN A LEVEL IN A GIRL WITH FACTOR XIII DEFICIENCY
Akbari A. - FACTOR XI DEFICIENCY IN SOUTHERN IRAN AND REVIEW OF LITERATURE
Akhavan S. - A 2 ADENINE INSERTION POLYMORPHISM IN THE FVII GENE 3'UTR IS ASSOCIATED WITH PERIPHERAL ARTERIAL DISEASE BUT NOT WITH VENOUS THROMBOSIS: RESULTS OF CASE-CONTROL STUDIES
Akhvlediani M.M.A. - APPLICATION OF LOW MOLECULAR-WEIGHT HEPARIN (NARDROPARINE) IN PATIENTS WITH LUNG CANCER
Akhvlediani M. - CORRELATION OF HDL CHOLESTEROL WITH SOME LABORATORY PARAMETERS AND CAROTID ARTERIES ATHEROSCLEROTIC LESIONS IN PATIENTS WITH HEART ISCHEMIC DESEASES
Akici F. - RADIOSYNOVECTOMY WITH YTRIUM-90 AND RHENIUM-186 IN HEMOPHILIC ARTHROPATY
  - THE RESULTS OF OUR FEBRILE NEUTROPENIA MANAGEMENT REPORTS FOR THREE YEARS
  - FX DEFICIENCY: CHARACTERISTICS AND TREATMENT OUTCOME OF SEVEN CASES
  - EVALUATION OF OUR CASES WITH GLANZMANN THROMBASTHENIA
Akinshina S.V. - ANTIPHOSPHOLIPID ANTIBODIES SPECTRUM IN WOMEN WITH RECCURENT FETAL LOSS SYNDROME
  - PATHOGENETIC PROPHYLAXIS OF RECCURENT FETAL LOSS SYNDROME IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND GENETIC THROMBOPHILIA
  - PROPHYLAXIS OF THROMBOEMBOLIC COMPLICATIONS IN PREGNANT WOMEN WITH THROMBOPHILIA
  - PROPHYLAXIS OF RECURENT PREECLAMPSIA IN PATIENTS WITH THROMBOPHILIA
Akita N. - REGULATION OF BREAST CANCER CELL GROWTH, METASTASIS AND ANGIOGENESIS BY PROTEIN C INHIBITOR
Akiyama M. - SEMAPHORIN 3A ANTAGONIZES AGONIST-INDUCED PI3 KINASE PATHWAY IN PLATELETS
Akkerman J. - A COMPREHENSIVE STUDY OF CANDIDATE GENES IN TWO SIGNALLING PATHWAYS TO IDENTIFY GENETIC VARIANTS THAT REGULATE PLATELET RESPONSIVENESS TO COLLAGEN AND ADP
Akkerman J.W.N. - ROLE OF GLYCOPROTEIN IBA MOBILITY IN PLATELET DESTRUCTION AND FUNCTION
Akkerman J.N. - EFFECT OF SR-BI DEFICIENCY ON PLATELET AGGREGATION AND SUSCEPTIBILITY TO THROMBOSIS
  - ACTIVATION OF HUMAN PLATELETS BY MISFOLDED PROTEINS
  - LDL-INDUCED PLATELET ACTIVATION INVOLVES SPECIFIC DOMAINS IN APOB100
Akkerman J. - INSULIN INHIBITS TISSUE FACTOR EXPRESSION IN MONOCYTES
Akram A. - HEMOSTASIS IN FACTOR VIII DEFICIENT MICE IS IMPROVED AFTER THE INFUSION OF MONOCYTE-DERIVED MICROPARTICLES
Aksu I. - THE EFFECT OF EXERCISE ON FIBRINOLYTIC AND COAGULATION SYSTEMS IN HEALTHY VOLUNTEERS
Aktay Ayaz N. - FX DEFICIENCY: CHARACTERISTICS AND TREATMENT OUTCOME OF SEVEN CASES
  - EVALUATION OF OUR CASES WITH GLANZMANN THROMBASTHENIA
  - THE RESULTS OF OUR FEBRILE NEUTROPENIA MANAGEMENT REPORTS FOR THREE YEARS
Akulich N.V. - IMAGE ANALYSIS OF LYMPHOCYTES CHROMATIN AT THE APOPTOSIS
Al Dieri R. - THE NECESSITY OF CONTINUOUS INDIVIDUAL CALIBRATION IN CONTINUOUS FLUOROGENIC MEASUREMENT OF THE THROMBIN GENERATION CURVE
Al Muslahi M. - EVALUATION OF A PRE-TEST CLINICAL SCORE FOR THE DIAGNOSIS OF HIT
Ala F.A. - A NOVEL CANDIDATE A/T789P MUTATION IDENTIFIED IN FIVE PATIENTS WITH TYPE 2N VON WILLEBRAND DISEASE FROM TWO DIFFERENT FAMILIES
  - GENETIC ANALYSIS OF PATIENTS WITH FACTOR XIII DEFICIENCY IN IRAN: REPORT OF FOUR NOVEL MUTATIONS
Ala F. - EPIDEMIOLOGIC, LABORATORY EVALUATION AND CLINICAL CHARACTERISTICS IN PATIENTS WITH THROMBOSIS
  - EPIDEMIOLOGY OF BERNARD SOULIER DISEASE
  - FACTOR VII GENOTYPE AND CLINICAL PROFILE IN 6 IRANIAN PATIENTS WITH CONGENITAL FACTOR VII DEFICIENCY
  - THROMBOSIS IN BETA THALASSEMIA MAJOR
  - VON WILLEBRAND DISEASE TYPES 2A MUTATION (C.4789CT, P.R1597W) IN THREE IRANIAN PATIENTS
  - FACTOR XI DEFICIENCY: THREE NOVEL MUTATIONS IN IRANIAN PATIENTS
Ala F.A. - THE RISK OF INHIBITOR DEVELOPMENT IN 1104 PATIENTS WITH HEMOPHILIA A ACCORDING TO FACTOR VIII GENOTYPE
  - GENETIC ANALYSIS OF BERNARD SOULIER PATIENTS IN IRAN: REPORT OF FIVE NOVEL MUTATIONS
Alabieva E.A. - PREVALENCE OF THROMBOPHILIA IN WOMEN WITH PREGNANCY LOSS AND GESTATIONAL OUTCOME IN WOMEN WITH DIAGNOSED THROMBOPHILIA FOLLOWING ANTITHROMBOTIC THERAPY
Alacacioglu I. - THE EFFECT OF EXERCISE ON FIBRINOLYTIC AND COAGULATION SYSTEMS IN HEALTHY VOLUNTEERS
Alahmad A. - RETRIEVABLE INFERIOR VENA CAVA (IVC) FILTERS IN A TERTIARY CARE POPULATION
Alamanni C. - CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND INFLAMMATION IN PATIENTS BEFORE AND AFTER CARDIAC SURGERY
Alamartine E. - RENAL IMPAIRMENT ESTIMATES TO PREDICT THE HAEMORRHAGE RISK IN 2170 PATIENTS TREATED BY HEPARIN. COCKCROFT-GAULT OR SIMPLIFIED MDRD?
Alatri A. - LOW MOLECULAR WEIGHT HEPARIN (LMWH) BRIDGING THERAPY DURING SUBTHERAPEUTIC INR LEVELS IN VTE HIGH RISK PATIENTS
  - ACCURACY AND COST EVALUATION OF A PORTABLE INR MONITOR
  - PROTHROMBIN TIME: COMPARISON BETWEEN DIFFERENT REAGENTS
  - PT INR: COMPARISON BETWEEN TWO DIFFERENT POINT OF CARE SYSTEMS
  - EVALUATION OF A NEW INR PORTABLE MONITOR
  - EVALUATION OF A NEW D-DIMER METHOD
Alavi S. - CHILDHOOD GERM CELL TUMOR PRECEDING BY CHRONIC LONGSTANDING DIC
Alavitoosi J. - EPIDEMIOLOGIC, LABORATORY EVALUATION AND CLINICAL CHARACTERISTICS IN PATIENTS WITH THROMBOSIS
  - EPIDEMIOLOGY OF BERNARD SOULIER DISEASE
Albalushi T.M. - CLINICAL PROFILE AND MOLECULAR BASIS OF GLANZMANN'S THROMBASTHENIA [GT] IN THE SULTANATE OF OMAN
  - CLINICAL PROFILE AND MOLECULAR BASIS OF GLANZMANN'S THROMBASTHENIA [GT] IN THE SULTANATE OF OMAN
Alban S. - INTERACTIONS WITH P-SELECTIN AND ANTIMETASTATIC ACTIVITIES OF NADROPARIN AND UFH
Albanyan A. - LACTADHERIN IS MORE SENSITIVE THAN ANNEXIN-V AT DETECTING PHOSPHATIDYLSERINE EXPOSURE WITHIN PLATELETS
Albayrak D. - CEREBRAL THROMBOSIS ASSOCIATED WITH HETEROZYGOUS FV LEIDEN MUTATION AND HIGH LIPOPROTEIN A LEVEL IN A GIRL WITH FACTOR XIII DEFICIENCY
Alberca I. - CLINICAL, GENETIC, FUNCTIONAL AND CONFORMATIONAL HETEROGENEITY OF CONGENITAL ANTITHROMBIN DEFICIENCY. RESULTS FROM 27 UNRELATED CASES
  - ANTITHROMBIN CAMBRIDGE II (A384S): AN UNDERESTIMATED GENETIC RISK FACTOR FOR VENOUS THROMBOSIS
Alberio L. - MONITORING THROMBIN GENERATION IN WHOLE BLOOD BY ELECTROCHEMISTRY - A NEW APPROACH FOR SCREENING THROMBOPHILIC AND HEMOPHILIC RISKS
  - DOSING LEPIRUDIN IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA AND VARIOUS DEGREES OF RENAL FUNCTION IMPAIRMENT
  - CLINICAL APPROACH TO HEPARIN-INDUCED THROMBOCYTOPENIA
Albers G.W. - ENOXAPARIN VERSUS UNFRACTIONATED HEPARIN FOR VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS IN ACUTE ISCHEMIC STROKE PATIENTS
Albers M. - CHARACTERIZATION OF COMMERCIALLY AVAILABLE VWF-CONTAINING FVIII CONCENTRATES BY VWF MULTIMER ANALYSIS
Albert J. - INCREASED THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) LEVELS IN EXPERIMENTAL HUMAN ENDOTOXEMIA IS CAUSED BY BOTH INFLAMMATORY RESPONSE AND THROMBIN GENERATION
Albert F.W. - UNEXPLAINED PROLONGED PLATELET FUNCTION ANALYZER (PFA-100) CLOSURE TIME INDUCED BY SAMPLE ANTICOAGULANT
Alberti A. - A MULTICENTER STUDY ON EARLY HEMORRHAGIC TRANSFORMATION IN ISCHEMIC STROKE: PRELIMINARY RESULTS
Alberto M.F. - EFFECT OF NYTROXYL (HNO) AND NITRIC OXIDE (NO) ON PROTEIN KINASE ACTIVATION PATHWAY IN HUMAN PLATELET
Alberto F. - D-DIMER VALUE AND ECHOCARDIOGRAPHIC CHANGES AS PREDICTORS OF THROMBOEMBOLIC COMPLICATIONS AFTER THE FONTAN OPERATION
  - HEMOSTATIC MARKERS AS PROGNOSTIC FACTORS IN ATRIAL FIBRILLATION. PRELIMINARY RESULTS OF A PROSPECTIVE STUDY
  - LOW MOLECULAR THIOLS, PRO-COAGULANT STATE AND NATURAL ANTIOXIDANT SYSTEM IN HEMODIALYSIS PATIENTS
Albiger N. - POLYMORPHISMS OF VON WILLEBRAND FACTOR (VWF) GENE PROMOTER MODULATE THE CORTICOSTEROID-MEDIATED INCREASE IN VWF LEVELS IN CUSHING'S SYNDROME: A POTENTIAL MODEL OF TRANSCRIPTIONAL REGULATION AND A NEW THROMBOTIC MARKER
Albisetti M. - SELF-CONTROL OF ORAL ANTICOAGULATION USING A PORTABLE PROTHROMBIN TIME MONITOR IN PAEDIATRIC CARDIAC PATIENTS
  - PORT--CATH-RELATED THROMBOSIS AND POSTTHROMBOTIC SYNDROME IN PAEDIATRIC ONCOLOGY PATIENTS: THE PACTOP STUDY
Albisinni R. - ACQUIRED AND INHERITED PREDISPOSING CONDITIONS IN PATIENTS WITH RETINAL VEIN OCCLUSION
Albrecht S. - BLOOD EOSINOPHILS STORE AND EXPOSE TISSUE FACTOR (TF) PROMOTION OF TRANSENDOTHELIAL MIGRATION
Alcaraz A. - BILLIARY CIRRHOSIS: CONFORMATIONAL EFFECTS AND CONSEQUENCES OF THE OXIDATION OF HEPATIC SERPINS
Aldama A. - ANGIOGENIC GENE THERAPY WITH VASCULAR ENDOTHELIAL GROWTH FACTOR FOR TREATING INTERMITTENT CLAUDICATION
Aldemir H. - FX DEFICIENCY: CHARACTERISTICS AND TREATMENT OUTCOME OF SEVEN CASES
  - EVALUATION OF OUR CASES WITH GLANZMANN THROMBASTHENIA
  - THE RESULTS OF OUR FEBRILE NEUTROPENIA MANAGEMENT REPORTS FOR THREE YEARS
AlDieri R. - ORAL ANTICOAGULATION SEVERELY IMPAIRS THE FUNCTION OF THE PROTEIN C SYSTEM
Aledort L.M. - MTHFR C677T HOMOZYGOSITY AND RECURRENT FETAL LOSS
  - EFFICACY OF A FVIII/VWF CONCENTRATE AS REPLACEMENT THERAPY IN PREVENTING EXCESSIVE BLEEDING IN SUBJECTS WITH CONGENITAL VON WILLEBRAND DISEASE (VWD) WHO UNDERWENT SURGICAL OR INVASIVE PROCEDURES
Aleil B. - MEGAKARYOCYTE-RESTRICTED MYH9 INACTIVATION DRAMATICALLY AFFECTS HAEMOSTASIS WHILE PRESERVING PLATELET AGGREGATION AND SECRETION RESPONSES
Aleksanin S.S. - AN INCREASE OF CELL LETHALITY IN IRRADIATED VASCULAR ENDOTHELIUM AND PROBLEM OF HAEMOSTASIS
Alessandrello Liotta A. - HEMORHEOLOGICAL PROFILE IN RETINAL VEIN OCCLUSION
  - ASSESSMENT OF CLOT LYSIS TIME TISSUE FACTOR-INDUCED BY EXOGENOUS T-PA IN HEALTHY SUBJECTS BY USING A MICROPLATE READER
  - LIPOPROTEIN (A) AND VENOUS THROMBOEMBOLISM IN ADULTS: A META-ANALYSIS
  - PROTEIN Z PLASMA LEVELS IN DIFFERENT LOCALIZATIONS OF ATHEROSCLEROTIC DISEASE
Alessandriello Liotta A. - HYPERVISCOSITY AS A POSSIBLE DETERMINANT OF INFARCT SIZE IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
Alessi M. - A MULTICENTRE PROSPECTIVE OPEN-LABEL STUDY ASSESSING PHARMACOKINETICS, CLINICAL EFFICACY AND SAFETY OF A TRIPLE-SECURED FIBRINOGEN CONCENTRATE: FIBRINOGENE T-I
Alessi M.C. - OBESITY, METABOLIC SYNDROME, AND VENOUS THROMBOEMBOLISM
  - RISK OF A FIRST VENOUS OR ARTERIAL EVENT IN CARRIERS OF A FAMILIAL THROMBOPHILIC DEFECT
Alessi M. - DISRUPTION OF PAI-1 CIRCADIAN RHYTHM IN OBESE SUBJECTS MAY EXPLAIN A CHANGE IN THE TIME OF ONSET OF MYOCARDIAL INFARCTION
  - CYP 2C19*2 AND MDR1+3435C ALLELES CONTRIBUTE TO LOW RESPONSE TO CLOPIDOGREL IN ACUTE CORONARY SYNDROME
Alessi M.C. - IDENTIFICATION OF 8 NOVEL MUTATIONS IN THE NON-MUSCLE MYOSIN HEAVY CHAIN 9 (MYH9) GENE IN 11 UNRELATED PATIENTS WITH MACROTHROMBOCYTOPENIA
  - PAI-1 GENE HAPLOTYPES ARE ASSOCIATED WITH MYOCARDIAL INFARCTION OCCURRENCE IN NON SMOKERS: THE HIFMECH STUDY
Aléssio A.C.M. - EVALUATION OF MILD HHCY IN THE DEVELOPMENT OF ATHEROSCLEROSIS IN APOE-DEFICIENT AND NORMAL MICE
Alexander D. - TWO PATIENTS WITH TYPE III PROTEIN S DEFICIENCY WHO UNDERWENT CARDIAC SURGERY WITH CARDIOPULMONARY BYPASS
Alexander S. - A NOVEL P2Y12 ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONIST THAT INHIBITS PLATELET AGGREGATION AND THROMBUS FORMATION IN RAT AND DOG MODELS
Alexandra J. - OVER-ANTICOAGULATION ASSOCIATED WITH COMBINED USE OF COUMARIN ANTICOAGULANTS AND TOPICAL ECONAZOLE OR BIFONAZOLE IN ELDERLY PATIENTS
Alexandrova E.N. - LONG-TERM OBSERVATION OF 280 PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND 74 PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME: 10-YEAR FOLLOW-UP
Alfinito F. - BUDD-CHIARI SYNDROME IN A PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENT WITH PREVIOUS CEREBRAL VENOUS THROMBOSIS
Alfonsova E.V. - POSSIBLE MECHANISMS OF THE DEVELOPMENT OF DIC SYNDROME
Alfter K. - HEPARIN AND BLEEDING HISTORY IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS
Alguel G. - SUCCESSFUL PREGNANCY OUTCOME IN A WOMAN WITH HOMOZYGOUS ANTITHROMBIN DEFICIENCY (99 LEUPHE MUTATION)
  - A HIGH PLATELET COUNT INDEPENDENTLY PREDICTS VENOUS THROMBOEMBOLISM IN CANCER PATIENTS
  - PREGNANCY OUTCOME IN WOMEN WITH THE LUPUS ANTICOAGULANT AND A HISTORY OF THROMBOEMBOLISM (TE)
Alhaddabi H. - CLINICAL PROFILE AND MOLECULAR BASIS OF GLANZMANN'S THROMBASTHENIA [GT] IN THE SULTANATE OF OMAN
Alhenc-Gelas M. - ORGARAN CROSS REACTIVITY WITH HEPARIN INDUCED THROMBOCYTOPENIA ANTIBODIES: REPORT OF 12 CASES
  - GENETIC ANALYSIS BY MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION IN PROTEIN S DEFICIENCY
Alhomsi K. - EVALUATION OF A NEW, AUTOMATED QUANTITATIVE FACTOR XIII ASSAY
Ali M. - DOSING EFFICACY AND SAFETY OF UNFRACTIONATED HEPARIN IN INFANTS WITH THROMBOTIC COMPLICATIONS
Aljada A. - INHIBITION OF CANCER AND INFLAMMATION-ASSOCIATED THROMBOSIS USING NOVEL INHIBITORS OF NFKB AND OXIDATIVE STRESS PATHWAYS
Alkayali A. - ROLE OF THYROID HORMONE ANALOGS IN ANGIOGENESIS AND THE DEVELOPMENT OF COLLATERALS IN RABBIT HIND LIMB ISCHEMIA MODEL
Allcott N. - CONSTITUTIVELY ACTIVE OR INACTIVE I DOMAINS AS PROBES FOR INTEGRIN BINDING TO COLLAGEN
Allemand E. - VENOUS THROMBOSIS DURING ORAL CONTRACEPTION IN NORMAL OR THROMBOPHILIC WOMEN WHO HAD REMAINED ASYMPTOMATIC DURING PAST PREGNANCIES
Allen D.J. - PLATELET ACTIVATION RESPONSE IS MORE SENSITIVE TO THROMBIN STIMULATION THAN IS PLATELET APOPTOSIS
Allen C. - QUALITY OF ANTICOAGULATION MANAGEMENT IN PRIMARY CARE PRACTICE
Al-Marwani A. - CHARACTERISATION OF THE MOLECULAR GENETIC DEFECTS UNDERLYING GLANZMANN'S THROMBASTHENIA IN JORDANIAN FAMILIES
Almasy L.A. - GENETIC DETERMINANTS OF NORMAL VARIATION IN ADAMTS-13 LEVELS: HERITABILITY ESTIMATE AND GENOME-WIDE SCAN
Almasy L. - GENETIC DETERMINANTS OF PLATELET-PLATELET AND PLATELET-LEUKOCYTE AGGREGATES. RESULTS FROM THE GAIT PROJECT
  - MAPPING QUANTITIVE TRAIT NUCLEOTIDES (QTN) IN THE F12 GENE REVEALED THAT THE C46T IS THE MAIN FUNCTIONAL VARIANT
Almeida-Dias A. - ROLE OF PLATELET GLYCOPROTEIN IB-ALPHA POLYMORPHISM IN PLATELET REACTIVITY
Almenar L. - DYSFUNCTION ENDOTHELIAL AND ANGIOGENIC ACTIVITY IN CHRONIC HEART FAILURE: ROLE OF ORAL ANTICOAGULANT THERAPY
  - INFLAMMATION, ENDOTHELIAL DYSFUNCTION AND ANGIOGENIC ACTIVITY IN STABLE HEART FAILURE PATIENTS
Almus-Jacobs F. - THE ROLE OF PLATELET GLYCOPROTEIN VI IN ARTERIAL THROMBOSIS
Alobaidi M. - MAJOR OBSTETRIC HAEMORRGHAGE IN LATE TERMINATION OF PREGNANCY
  - MAJOR OBSTETRIC HAEMORRHAGE IN LATE TERMINATION OF PREGNANCY
Aloeva M.M.A. - APPLICATION OF LOW MOLECULAR-WEIGHT HEPARIN (NARDROPARINE) IN PATIENTS WITH LUNG CANCER
Aloeva M.A. - HEMOSTASIS DISORDERS MARKERS IN INTRACRACRANIAL MENONGIOMAS (IM) PATIENTS
Alonso A. - SEROTONERGIC MECHANISMS IN HAEMOSTASIS: A CONNECTION BETWEEN MAJOR DEPRESSION AND THROMBOTIC RISK
Alonso B. - ROLE OF 4G/5G PROMOTER POLYMORPHISM OF PLASMINOGEN ACTIVATOR INHIBITOR-1 GENE IN OUTCOME OF SEPSIS
Alonso I. - RECURRENT ARTERIAL THROMBOSIS WITH FACTOR V LEIDEN HOMOZYGOCY
Alsabeh R. - CORRELATION OF PF4 ELISA (PF4) OPTICAL DENSITY RESULTS AND CLINICAL FINDINGS TO ACCURATELY DIAGNOSE HEPARIN INDUCED THROMBOCYTOPENIA (HIT)
Althabe M. - USE OF RECOMBINANT ACTIVATED FACTOR VII IN NON-HEMOPHILIC CHILDREN
Althaus H. - QUANTITATION OF D-DIMER BY LOCI TECHNOLOGY
Altiay G. - THROMBOSIS IN PATIENTS WITH LUNG CANCER AND THE EFFECTIVENESS OF LOW WARFARIN PROPHYLAXIS ON PATIENTS' SURVIVAL
Altisent C. - ATS-13 ACTIVITY AS A COMMON MARKER OF THE ENDOTHELIAL DYSFUNCTION DEVELOPING IN THROMBOTIC MICROANGIOPATHIES OF DIFFERENT ORIGIN
Altmann B. - PROTEIN DISULFIDE ISOMERASE (PDI) UNCOVERS TISSUE FACTOR (TF)-DEPENDENT FIBRIN FORMATION AFTER VESSEL INJURY
Altomare I. - MTHFR C677T HOMOZYGOSITY AND RECURRENT FETAL LOSS
Altomonte F. - RANDOMISED, OPEN, PROSPECTIVE, MULTICENTER PILOT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ACTIVATED RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN ACUTE INTRACEREBRAL HAEMORRHAGE IN PATIENTS TREATED WITH ORAL ANTICOAGULANT OR ANTIPLATELET AGENTS
Altun M. - RADIOSYNOVECTOMY WITH YTRIUM-90 AND RHENIUM-186 IN HEMOPHILIC ARTHROPATY
Altun A. - IS PLATELET HYPERREACTIVITY DEFINING STICKY PLATELET SYNDROME A GLOBAL PHENOMENON? THE STUDY OF DETERMINATON OF NORMAL VALUES IN TURKISH HEALTHY SUBJECTS
Altuncu E. - RECOMBINANT FVIIA USE IN THREE PRETERM NEONATES WITH DISSEMINATED INTRAVASCULAR COAGULATION
Alvarado L.R. - A NOVEL MUTATION IN EXON 10 OF FACTOR XIII SUBUNIT B
  - FACTOR XIII PHARMACOKINETICS
Alvarado-Vazquez N. - EFFECT OF PROLAME, A 17 BETA-AMINOESTROGEN DERIVATIVE, ON CELL HEMOSTASIS
Alvarez L. - DEFICIENCY OF SRC HOMOLOGY 2 DOMAIN-CONTAINING INOSITOL 5-PHOSPHATASE 1 (SHIP1) AFFECTS PLATELET RESPONSES AND THROMBUS GROWTH
Alvarez H. - ANGIOGENIC GENE THERAPY WITH VASCULAR ENDOTHELIAL GROWTH FACTOR FOR TREATING INTERMITTENT CLAUDICATION
Alvarez M. - IMMUNE TOLERANCE INDUCTION WITH VIII-CONTAINING FACTOR VWF
Alvarez-Roman M.T. - RADIOSYNOVIORTHESIS IS NECESSARY IN HEMOPHILIC PATIENTS DESPITE PROHYLAXIS
Alves M. - RFVIIA IN THE TREATMENT OF GLANZMANN'S THROMBASTHENIA - CASE REPORT
Alves B.E. - HEMOSTATIC CHANGES IN BRAZILIAN SPOTTED FEVER
Alvi A. - A MUTATION IN EXON 27 OF THE VWF GENE CAUSING TYPE 2M AND TYPE 3 VON WILLEBRAND DISEASE IN THREE PATIENTS IN A FAMILY FROM THE WEST OF SCOTLAND
Alvisi P. - MUTATED POSITION OF NMHC-A PREDICTS THE NATURAL HISTORY OF MYH9-RELATED DISEASE
Alzadjali S. - CLINICAL PROFILE AND MOLECULAR BASIS OF GLANZMANN'S THROMBASTHENIA [GT] IN THE SULTANATE OF OMAN
Al-Zahrani F.M. - CHARACTERISATION OF PREDICTED OESTROGEN RESPONSE ELEMENTS IN THE ITGA2 GENE PROMOTER
Amano K. - DOUBLE MUTATION, A 2-BP DELETION AND VAL 211ILE, IN THE BLOOD COAGULATION FACTOR IX GENE IN A PATIENT WITH SEVERE HEMOPHILIA B
  - CONTINUOUS INFUSION OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE IN PATIENTS WITH CONGENITAL VON WILLEBRAND DISEASE
  - FACTOR V DEFICIENCY DUE TO A NOVEL HOMOZYGOUS MUTATION: FV N468S, BUT NO BLEEDING TENDENCY
  - ANALYSIS OF DISCREPANT ASSAY-DETERMINED ACTIVITY LEVELS OF FACTOR VIII ASSOCIATED WITH R531H MUTATION
  - CHARACTERIZATION OF A LARGE DELETION THAT LEADS TO CONGENITAL FACTOR XIII DEFICIENCY
Amarenco P. - A ROLE FOR PLATELET ACTIVATION IN LACUNAR STROKE?
Amato M. - E-SELECTIN AND TFPI ARE ASSOCIATED WITH CAROTID INTIMA-MEDIA THICKNESS IN STABLE CORONARY PATIENTS: THE BASELINE FINDINGS OF THE MIAMI STUDY
  - ASSOCIATION OF TISSUE FACTOR A-603G GENOTYPE WITH CAROTID INTIMA-MEDIA THICKNESS IN SUBJECTS IN CARDIOVASCULAR RISK PREVENTION
Amaya M. - THERAPEUTIC ANTIBODIES AGAINST CD40 LIGAND, TNF-ALPHA AND VEGF SHARE MECHANISTIC FEATURES IN COMMON WITH PLATELET ACTIVATING ANTIBODIES IN HEPARIN-INDUCED THROMBOCYTOPENIA (HIT)
  - HYPERCOAGULABILITY IN OVARIAN CANCER REVISITED: A PROSPECTIVE ANALYSIS OF COAGULATION AND PLATELET ACTIVATION MARKERS
  - PROSPECTIVE EVALUATION OF LABORATORY TESTS FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
Ambaglio C. - CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA (CAMT): CLINICAL AND BIOLOGICAL CHARACTERIZATION OF FIVE NEW MUTATIONS
Ambily A. - AKT ACTIVATION BY PHOSPHAPHATIDYLINOSITOL-3,4,5-TRISPHOSPHATE IN HUMAN PLATELETS IS DEPENDENT ON EXTRACELLULAR CA2+
Ameling C. - EFFECTS OF PARTICULATE MATTER AIR POLLUTION ON INFLAMMATION AND HAEMOSTASIS
Amelot A.A. - PLATELET FACTOR 4 (PF4/CXCL4) SEALS BLOOD CLOTS BY ALTERING THE STRUCTURE OF FIBRIN
Amelot A. - THROMBIN ADSORBED TO A FIBRIN CLOT CONFERS ANGIOGENIC AND HEMOSTATIC PROPERTIES ON ENDOTHELIAL PROGENITOR CELLS
Amengual O. - DIAGNOSTIC SIGNIFICANCE OF TESTING ANTI-BETA2-GLYCOPROTEIN I ANTIBODIES FOR THE ANTIPHOSPHOLIPID SYNDROME
  - THE P38 MITOGEN-ACTIVATE PROTEIN KINASE MAPK) PATHWAY MEDIATES THE INDUCTION OF TISSUE FACTOR EXPRESSION BY PHOSPHATIDYLSERINE-DEPENDENT ANTIPROTHROMBIN ANTIBODIES WITH LUPUS ANTICOAGULANT ACTIVITY
Ameziane N. - FACTOR V LEIDEN (G1691A) AND PROTHROMBIN (G20210A) GENOTYPING BY HIGH-RESOLUTION MELT ANALYSIS (HRM) AND SYTO 9 FLUORESCENT DYE ON THE ROTOR-GENE 6000 HRM
Amin S.N. - THROMBOPHILIA & RECURRENT FETAL LOSS: SHOULD WE SCREEN BOTH PARENTS ?
Amiral J.J. - FACTORS AFFECTING THE FACTOR VIII:C REACTIVITY WHEN TESTED IN PURIFIED SYSTEMS WITH CHROMOGENIC ASSAYS
  - NEW APPROACH FOR DETECTION OF HEPARIN DEPENDENT ANTIBODIES AND RISK ASSESSMENT FOR HEPARIN INDUCED THROMBOCYTOPENIA
Amiral J. - DEVELOPMENT AND VALIDATION OF A MULTIPLEXED FLUORESCENT BEAD-BASED IMMUNOASSAY FOR SIMULTANEOUS QUANTIFICATION OF COAGULATION AND FIBRINOLYSIS PARAMETERS IN HUMAN PLASMA
Amiral J.J. - INCIDENCE OF THE VARIOUS HEPARIN DEPENDENT ANTIBODY ISOTYPES IN A GROUP OF PATIENTS WITH HEPARIN INDUCED THROMBOCYTOPENIA
  - MICROPARTICLES PROCOAGULANT ACTIVITY IN CITRATED PLASMA
  - CLASSIFICATION OF FACTOR V-LEIDEN CARRIERS BY QUANTITATIVELY MEASURING ITS PROCOAGULANT ACTIVITY COMPARATIVELY TO THAT OF FACTOR V
  - QUANTITATIVE MEASUREMENT OF FACTOR V-LEIDEN WITH A NEW ONE STEP, CALIBRATED, CLOTTING METHOD
Amiri A. - INFLUENCE OF INHERITED THROMBOPHILIA WITH RECURRENT PREGNANCY LOSS
Amirkhosravi A. - HYPERCOAGULABILITY IN OVARIAN CANCER REVISITED: A PROSPECTIVE ANALYSIS OF COAGULATION AND PLATELET ACTIVATION MARKERS
  - ANTI-METASTASIS EFFICACY OF LOW MOLECULAR WEIGHT HEPARIN IN EXPERIMENTAL METASTASIS MODEL
  - THERAPEUTIC ANTIBODIES AGAINST CD40 LIGAND, TNF-ALPHA AND VEGF SHARE MECHANISTIC FEATURES IN COMMON WITH PLATELET ACTIVATING ANTIBODIES IN HEPARIN-INDUCED THROMBOCYTOPENIA (HIT)
  - PROSPECTIVE EVALUATION OF LABORATORY TESTS FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
  - BLOOD-BORNE BUT NOT ENDOTHELIAL CD40 PROMOTES EXPERIMENTAL LUNG METASTASIS
  - IMPACT OF TISSUE FACTOR-BEARING MICROPARTICLES DERIVED FROM TUMOR CELLS ON COAGULATION ACTIVATION
Amistà P. - INTRACRANIAL STENTING IN FOUR PATIENTS WITH ACUTE ISCHEMIC STROKE
Amitrano L. - COMMON GENE MUTATIONS AND VENOUS THROMBOEMBOLISM: DISTINCT ROLES IN DIFFERENT CLINICAL SETTINGS
Amlie-Lefond C. - TPA IN CHILDREN WITH ARTERIAL ISCHEMIC STROKE: CASES FROM THE IPSS COMPARED WITH LITERATURE-BASED CASES
Ammar S. - ASSOCIATION OF HYPERHOMOCYSTEINEMIA WITH RESTENOSIS
Ammollo T.C. - LPS-STIMULATED MONOCYTES INHIBIT FIBRINOLYSIS THROUGH A TISSUE FACTOR (TF)-DEPENDENT, TAFI-MEDIATED MECHANISM
Amor Otero M. - RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) IN THE TREATMENT OF CRITICAL HAEMORRHAGE. A SINGLE CENTRE EXPERIENCE
Amor Otero M.A. - "PRIMARY" PROPHYLACTIC TREATMENT WITH RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) DURING INMUNE TOLERANCE IN A HAEMOPHILIC CHILD
Amore C. - PERSISTENT PLATELET ACTIVATION IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH LOW DOSES OF ASPIRIN
  - LEPTIN INDUCES TISSUE FACTOR EXPRESSION IN HUMAN MONOCYTES
  - ANTI-INFLAMMATORY EFFECS OF CLOPIDOGREL IN THE MOUSE
  - GLYCOGEN SYNTHASE KINASE-3 NEGATIVELY REGULATES TISSUE FACTOR GENE EXPRESSION IN MONOCYTES INTERACTING WITH ACTIVATED PLATELETS
Amoriello A.A.A. - A B3 ASP217VAL SUBSTITUTION IN A PATIENT WITH VARIANT GLANZMANN THROMBATHENIA SEVERELY AFFECTS INTEGRIN AIIBB3 FUNCTIONS
Amoriello A. - DESMOPRESSIN IN PATIENTS WITH CONGENITAL DISORDERS OF PRIMARY HAEMOSTASIS: FOUR YEAR PROSPECTIVE EVALUATION
Anabuki J. - THE ANTI-COAGULANT AND THE ANTI-THROMBOTIC EFFECT OF MCC-977, A NOVEL ORALLY-ACTIVE THROMBIN INHIBITOR
  - PHARMACOLOGICAL CHARACTERIZATION OF AN ORAL DIRECT THROMBIN INHIBITOR, MCC-977: HIGH THROMBIN SPECIFICITY AND LOW HEMORRHAGIC PROFILE
Anand S.S. - COMPARISON OF IMPEDANCE WHOLE BLOOD AGGREGATION AND OPTICAL PLATELET-RICH PLASMA AGGREGATION TO MEASURE THE ANTIPLATELET EFFECT OF ASPIRIN IN HEALTHY CONTROLS AND IN PATIENTS WITH PERIPHERAL ARTERY DISEASE (PAD)
Anastasio R. - LIMITED VERSUS EXTENDED ULTRASONOGRAPHY FOR THE DIAGNOSIS OF CLINICALLY SUSPECTED DEEP VEIN THROMBOSIS. A RANDOMIZED STUDY
  - PERIOPERATIVE BRIDGING THERAPY WITH LOW MOLECULAR WEIGH HEPARIN IN PATIENTS REQUIRING INTERRUPTION OF LONG-TERM ORAL ANTICOAGULANT THERAPY
  - ENDOGENOUS THROMBIN POTENTIAL IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOSIS
  - THE PERSISTANCE OF RESIDUAL VEIN THROMBOSIS, AFTER AN EPISODE OF DEEP VEIN THROMBOSIS, AND THE RISK OF NEW OVERT CANCER AND CARDIOVASCULAR DISEASE
Anastasopoulou I. - PRELIMINARY RESULTS ON EFFECTIVENESS AND SAFETY OF COMBINED ANTICOAGULANT AND ANTIPLATELET THERAPY
  - SAFETY AND EFFICACY OF TINZAPARIN ADMINISTRATION DURING PREGNANCY
  - COAGUCHEK XS IN COMPARISON TO BCS ANALYZER. RESULTS IN AN OUTPATIENT ANTICOAGULATION CLINIC, FOCUSED IN METAL VALVE DISEASE
  - DOES ADMINISTRATION OF LANSOPRAZOLE AFFECT ASA ANTIPLATELET FUNCTION IN HIGH RISK CARDIOVASCULAR PATIENTS? PRELIMINARY RESULTS
  - CONTRIBUTION OF ROTATION THROMBOELASTOGRAPHY (RT) IN PERIOPERATIVE MANAGEMENT OF PATIENTS WITH GLAZMANN'S THROMBASTHENIA (GT)
Ancona E. - RECOMBINANT HUMAN ACTIVATED PROTEIN C (RHAPC) IN PIG-TO-PRIMATE XENOTRANSPLANTATION
Anders B. - PLATELET EP3 RECEPTORS AS TARGETS FOR ANTITHROMBOTIC AGENTS - COMPARISON OF DG-041 WITH ASPIRIN AND AR-C69931
Anders R. - EP3 RECEPTORS - A NEW TARGET FOR INHIBITION OF PLATELET AGGREGATION AND PLATELET-LEUCOCYTE CONJUGATE FORMATION
Andersen S. - EVALUATION OF THROMBOELASTOGRAPHY (TEG) ASSAYS FOR MONITORING EX VIVO EFFECT OF RFVIIA (NOVOSEVEN) IN HAEMOPHILIA A AND B PATIENTS
Andersen E. - EVALUATION OF THROMBOELASTOGRAPHY (TEG) ASSAYS FOR MONITORING EX VIVO EFFECT OF RFVIIA (NOVOSEVEN) IN HAEMOPHILIA A AND B PATIENTS
Andersen M.D. - FXIII VARIANTS WITH ALTERED THROMBIN ACTIVATION RATES
Andersen A.S. - FXIII VARIANTS WITH ALTERED THROMBIN ACTIVATION RATES
Andersen K.V. - IMPROVED PROCOAGULANT AND PHARMACOKINETIC PROPERTIES OF TWO NOVEL RECOMBINANT HUMAN FACTOR VIIA VARIANTS PREPARED BY DIRECTED MOLECULAR EVOLUTION AND RATIONAL DESIGN
Andersen M.D. - PROBING THE ORIGINS OF ACTIVITY ENHANCEMENT IN FACTOR VIIA (FVIIA) VARIANTS BY HYDROGEN EXCHANGE MASS SPECTROMETRY (HX-MS)
Andersen T.O. - TISSUE FACTOR PATHWAY INHIBITOR (TFPI) POLYMORPHISMS, HORMONE REPLACEMENT THERAPY (HRT) AND RISK OF VENOUS THROMBOEMBOLISM (VTE)
  - EXPRESSION OF THE TFPI V264M MUTANT IN VASCULAR CELL CULTURES INVOLVES STABILITY OF MRNA
Anderson D.R. - ACCURACY AND USEFULNESS OF A CLINICAL PREDICTION RULE AND D-DIMER TESTING IN EXCLUDING DEEP VEIN THROMBOSIS (DVT) IN CANCER PATIENTS
Anderson F.A. - EFFECT OF BLOOD SALVAGE AND RE-INFUSION ON VTE COMPLICATIONS IN PATIENTS UNDERGOING ELECTIVE MAJOR ORTHOPEDIC SURGERY
Anderson D. - EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH INR VALUES OF MORE THAN 10.0: RESULTS OF A PROSPECTIVE COHORT STUDY
  - DALTEPARIN THROMBOPROPHYLAXIS IN CRITICALLY ILL PATIENTS WITH SEVERE RENAL INSUFFICIENCY: THE DIRECT STUDY
Anderson D.R. - PSYCHOLOGICAL IMPACTS OF GENETIC TESTING FOR THROMBOPHILIA ON FIRST DEGREE RELATIVES OF PATIENTS WITH VENOUS THROMBOEMBOLISM AND A THROMBOPHILIA A PILOT STUDY
Anderson F.A. - LATE BREAKING CLINICAL TRIAL: A LARGE-SCALE, GLOBAL OBSERVATIONAL STUDY OF VENOUS THROMBOEMBOLISM RISK AND PROPHYLAXIS IN THE ACUTE HOSPITAL CARE SETTING: THE ENDORSE STUDY
Anderson D. - EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH ELEVATED INR VALUES: RESULTS OF RANDOMIZED TRIAL EXAMINING CLINICAL OUTCOMES
Anderson D.R. - A PILOT STUDY TO ASSESS THE FEASIBILITY OF A MULTICENTER TRIAL FOR THE MANAGEMENT OF ASYMPTOMATIC PERSONS WITH A THROMBOPHILIA
Andersson M. - A CHROMOGENIC METHOD FOR DETERMINATION OF FIXA IN PURIFIED PREPARATIONS
  - CPU INHIBITION WITH AZD9684: PROFIBRINOLYTIC EFFECTS IN ACUTE PE PATIENTS
Andersson E. - DALTEPARIN SHORTENS HUMAN LABOR
Andjelkovic N. - COAGULATION ABNORMALITIES IN WOMEN WITH VERIFIED MENORRHAGIA IS IT TIME FOR INCLUSION OF COAGULATION SCREENING IN DIAGNOSTIC ALGORITHM?
Ando Y. - ACTIVATED PROTEIN C INCREASES TISSUE FACTOR EXPRESSION ON HUMAN UMBILICAL ENDOTHELIAL CELL BY EPCR-DEPENDENT BUT PAR-1-INDEPENDENT MANNER
Ando T. - FACTOR V DEFICIENCY DUE TO A NOVEL HOMOZYGOUS MUTATION: FV N468S, BUT NO BLEEDING TENDENCY
Andolj[scaron]ek D. - INHIBITOR DEVELOPMENT IN 3 PATIENTS WITH HEMOPHILIA A AFTER INTENSIVE EXPOSURE TO FVIII CONCENTRATES BY CONTINUOUS INFUSION DATA FROM SLOVENIA
Andon Saavedra C. - "PRIMARY" PROPHYLACTIC TREATMENT WITH RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) DURING INMUNE TOLERANCE IN A HAEMOPHILIC CHILD
  - SPANISH REGISTRY OF HEPARIN-INDUCED THROMBOCYTOPENIA (RETIH). PRELIMINARY DATA
Andón Saavedra C. - RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) IN THE TREATMENT OF CRITICAL HAEMORRHAGE. A SINGLE CENTRE EXPERIENCE
Andrade-Gordon P. - PROTEASE-ACTIVATED RECEPTOR 2 (PAR-2) A NOVEL TARGET TO PREVENT FIX INHIBITOR FORMATION
Andre P. - PRT060128, A NOVEL, DIRECT-ACTING ORALLY AVAILABLE P2Y12 ANTAGONIST, CONFERS SUPERIOR ANTITHROMBOTIC ACTIVITY OVER CLOPIDOGREL IN A MOUSE THROMBOSIS MODEL
Andre S. - EXPOSED MANNOSYLATION ON THERAPEUTIC FACTOR VIII MEDIATES ITS ENDOCYTOSIS BY HUMAN DENDRITIC CELLS LEADING TO ACTIVATION OF CD4+ T LYMPHOCYTES
Andre P. - INITIAL INTRAVENOUS EXPERIENCE WITH PRT060128 (PRT128), AN ORALLY-AVAILABLE, DIRECT-ACTING, AND REVERSIBLE P2Y12 INHIBITOR
  - DIFFERENTIAL EFFECTS OF ANTI-PLATELET DRUGS ON THROMBUS FORMATION AND THROMBUS STABILITY
  - ANTAGONISM OF INTRINSIC PATHWAY INHIBITS TISSUE FACTOR (TF)-INITIATED COAGULATION IN A PLATELET-DEPENDENT WHOLE BLOOD FLOW ASSAY
André E. - ALL PROTEIN S (PS) EPIDERMAL GROWTH FACTOR LIKE DOMAINS (EGFS) SIGNIFICANTLY PARTICIPATE TO ACTIVATED PROTEIN C (APC) COFACTOR ACTIVITY
Andre P. - MEASUREMENT OF THROMBUS STABILITY PREDICTS CORONARY EVENTS POST-PERCUTANEOUS CORONARY INTERVENTION (PCI)
Andreassen A.K. - ELEVATED SERUM LEVELS OF LIGHT IN PULMONARY ARTERIAL HYPERTENSION-POTENTIAL INVOLVEMENT IN THROMBUS FORMATION
Andréasson A.C. - THE ORAL DIRECT THROMBIN INHIBITOR AZD0837 REDUCES THROMBUS FORMATION IN A RAT MODEL
Andreeva T.A. - EFFICACY AND SAFETY OF FVIII WITH PEGYLATED LIPOSOMES IN HAEMOPHILIA A
Andrei-Selmer C. - SEVERE NEONATAL ALLOIMMUNE THROMBOCYTOPENIA CAUSED BY LOW-AVIDITY ANTI-HPA-1A ALLOANTIBODIES
Andreozzi G.M. - GRADUATED COMPRESSION STOCKINGS (GCS) VERSUS LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) FOR PREVENTION OF DEEP VEIN THROMBOSIS (DVT) AFTER KNEE ARTHROSCOPY (KA). A RANDOMISED STUDY (KANT)
  - INADEQUATE CARDIOVASCULAR PREVENTION AND DIAGNOSTIC VASCULAR GUIDELINES ADHERENCE IN OUTPATIENTS: AN OBSERVATIONAL STUDY IN A COHORT OF NORTHERN ITALY
  - BENIGN OUTCOME OF OBJECTIVELY PROVEN SPONTANEOUS RECANALIZATION OF INTERNAL CAROTID ARTERY OCCLUSION: LONG-TERM FOLLOW UP
Andrews R.K. - PROGRAMMED AUTOLOGOUS CLEAVAGE OF PLATELET RECEPTORS
  - RAPID LIGAND-INDUCED DIMERIZATION OF PLATELET GLYCOPROTEIN VI
  - CONTROL SHEDDING OF GPIB-IX-V AND GPVI BY ADAM FAMILY METALLOPROTEINASES
Androutsopoulos G. - FV LEIDEN, FII G20210A AND MTHFR T677T GENOTYPES: IS THEIR EVALUATION A USEFUL TOOL IN THE ETIOLOGICAL APPROACH OF THE EARLY RECURRENT PREGNANCY LOSSES IN THE GREEK POPULATION?
  - INHERITED THROMBOPHILIA: INCIDENCE AND IMPACT ON PERINATAL OUTCOME IN SOUTH-WESTERN GREECE
Anelli T. - MECHANISMS COUPLING PROTEIN FOLDING AND TRANSPORT AT THE ER-GOLGI INTERFACE: ROLE IN F5F8D AND OTHER DISEASES
Anfosso F. - COMPLEX MECHANISMS CONTROLLING THE THROMBIN-INDUCED GENERATION OF ENDOTHELIAL MICROPARTICLES
Angchaisuksiri P. - PROTEIN C MUTATIONS IN THAI PATIENTS WITH VENOUS THROMBOEMBOLISM
  - FIBRINOGEN THR312ALA BUT NOT FXIIIA VAL34LEU AND FXIIIB HIS95ARG POLYMORPHISMS ASSOCIATED WITH THAI DEEP VENOUS THROMBOSIS
Angeloni F. - COMPARISON OF THE ASSERACHROM VON WILLEBRAND FACTOR ANTIGEN ASSAY AND THE LIATEST VWF ASSAY AUTOMATED ON THE AMAX 200 COAGULATION ANALYZER IN HUMAN AND CANINE PLASMA SAMPLES
Angenent W. - INHERENT VARIATION INDONOR PLATELET REACTIVITY CONTRIBUTES TO THE QUALITY OF APHERESIS PLATELETS
  - A COMPREHENSIVE STUDY OF CANDIDATE GENES IN TWO SIGNALLING PATHWAYS TO IDENTIFY GENETIC VARIANTS THAT REGULATE PLATELET RESPONSIVENESS TO COLLAGEN AND ADP
  - THE EFFECT OF APHERESIS ON DONORS' PLATELETS
  - DIFFERENCES IN PLATELET RESPONSE TO ADP AND CRP ARE CORRELATED WITH VARIATION IN THE RESTING PLATELET TRANSCRIPTOME
Angerami R.N. - HEMOSTATIC CHANGES IN BRAZILIAN SPOTTED FEVER
Angles-Cano E. - CORTICAL NEURONS AGGREGATE IN RESPONSE TO PLASMIN FORMED AT THEIR SURFACE BY TPA
Angos V. - EFFECT OF AGING ON PLASMINOGEN ACTIVATOR INHIBITOR-1 EXPRESSION IN RAT TISSUES. POSSIBLE LINK BETWEEN INSULIN RESISTANCE AND CARDIOVASCULAR RISK
Ankri A. - COMPARISON OF TWO WHOLE BLOOD PLATELET FUNCTION ASSAYS: PFA-100 AND A NEW MULTIPLE ELECTRODE AGGREGOMETRY (MULTIPLATE) FOR CONTROL OF ASPIRIN AND/OR CLOPIDOGREL EFFECT
Annichino-Bizzacchi J.M. - SIMULTANEOUS BLEEDING AND THROMBOSIS AS THE INITIAL PRESENTATION OF SUPERWARFARIN POISONING
  - MOLECULAR AND FUNCTIONAL CHARACTERIZATION OF FVIII MUTATIONS IN A FEMALE WITH SEVERE HEMOPHILIA A
  - HEMOSTATIC CHANGES IN BRAZILIAN SPOTTED FEVER
  - EVALUATION OF MILD HHCY IN THE DEVELOPMENT OF ATHEROSCLEROSIS IN APOE-DEFICIENT AND NORMAL MICE
  - DAPSONE TREATMENT IN STEROID-DEPENDENT OR REFRACTORY ADULT ITP PATIENTS CAN AVOID IMMEDIATE SPLENECTOMY AFTER STEROID FAILURE
  - ANALYSIS OF MICROPARTICLES IN DEEP VENOUS THROMBOSIS AND ANTIPHOSPHOLIPID SYNDROME PATIENTS AND CARRIERS OF LEIDEN FACTOR V
  - THE ROLE OF FACTOR VIII IN THE DEVELOPMENT OF ATHEROSCLEROTIC LESIONS IN MURINE MODELS
  - DUAL GENE TRANSFER OF FGF-2 AND PDGF-BB USING PLASMID DNA PROMOTES EFFECTIVE ANGIOGENESIS AND ARTERIOGENESIS IN A RODENT MODEL OF HINDLIMB ISCHEMIA
  - ANALYSIS OF THE GENETIC EXPRESSION OF INFLAMMATORY MEDIATORS IN MONONUCLEAR CELLS FROM DEEP VENOUS THROMBOSIS PATIENTS
Anosov A. - ENOXAPARIN VERSUS HEPARIN PROPHYLAXIS FOR VENOUS THROMBOEMBOLISM AFTER ABDOMINAL ONCOLOGIC SURGERY: A RANDOMIZED DOUBLE-BLIND CONTROLLED TRIAL
Ansell J. - EFFICACY AND SAFETY OF WARFARIN MANAGEMENT IN US ANTICOAGULATION CLINICS
  - FACTOR XA OR THROMBIN: IS FACTOR XA A BETTER TARGET
Anson J. - VICENZA MUTATION R1205H IDENTIFIED IN TWO TYPE 1 VON WILLEBRAND DISEASE FAMILIES FROM ISRAEL
Antevska Z. - HOSPITALISATION FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD- IS IT ALWAYS NECESSARY?
  - A RARE CONGENITAL BLEEDING DISORDER: F.VII DEFICIENCY (CASE REPORT)
Antoine G. - MILD CONGENITAL ADAMTS13 DEFICIENCY DUE TO ONE MISSENSE MUTATION TOGETHER WITH FOUR AMINO ACID POLYMORPHISMS IN A PATIENT WITH FAMILIAL RECURRENT ISCHEMIC STROKE
Antonaci F.C. - FACTOR VIIA-ANTITHROMBIN COMPLEXES IN HUMAN PLASMA
Antonelli C. - A PROPOSAL OF SCORING SYSTEM IN ASSESSMENT OF THROMBOTIC RISK IN CANCER PATIENT. A MONOCENTRIC STUDY
Antonelli F. - APPLICABILITY OF D-DIMER IN RULING OUT VENOUS THROMBOEMBOLISM (VTE) IN ELDERLY MEDICAL PATIENTS: COMPARISON BETWEEN IMMUNOTURBIDIMETRIC AND ELISA (ELFA) METHODS
Antoniak S. - VIRAL MYOCARDITIS IS A HYPERCOAGULATIVE STATE. INCREASED TISSUE FACTOR EXPRESSION AND PLASMA THROMBOGENICITY
Antonijevic N.M. - INVESTIGATION OF ACQUIRED VON WILLEBRAND'S SYNDROME IN PATIENTS WITH HYPOTHYROIDISM
Antonijevic N. - THE 3'UTR PROTHROMBIN GENE POLYMORPHISMS IN THROMBOHILIC SERBIAN POPULATION
Antonino M. - EFFECT OF BIVALIRUDIN VS. BIVALIRUDIN WITH EPTIFIBATIDE ON PLATELET ACTIVATION AND AGGREGATION IN PATIENTS RECEIVING CHRONIC CLOPIDOGREL THERAPY UNDERGOING ELECTIVE PCI
Antonioli E. - A SURVEY ON POST-SURGERY OUTCOMES IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA IN A RETROSPECTIVE COHORT
Antoniucci D. - LOW RESPONSIVENESS TO CLOPIDOGREL AND STENT THROMBOSIS
  - CLINICAL DETERMINANTS OF PLATELET FUNCTION IN PATIENTS WITH CAD UNDERGOING CORONARY ANGIOGRAPHY AND TREATED BY DUAL ANTIPLATELET THERAPY
  - ASSOCIATION OF THE G681A POLYMORPHISM OF CYP2C19 GENE WITH RESPONSE VARIABILITY TO DUAL ANTIPLATELET TREATMENT IN HIGH RISK VASCULAR DISEASE PATIENTS
Antonucci E. - POST-TREATMENT PLATELET FUNCTION PREDICTS MYOCARDIAL INJURY IN ACUTE MYOCARDIAL INFARCTION PATIENTS UNDERGOING PRIMARY PCI
  - MAXIMAL AND LATE ADP INDUCED PLATELET AGGREGATION IN CORONARY ARTERY DISEASE PATIENTS ON DUAL ANTIPLATELET THERAPY
  - THE QUALITY OF ANTICOAGULATION ON FUNCTIONAL OUTCOME AND MORTALITY FOR TIA/STROKE IN ATRIAL FIBRILLATION PATIENTS
  - PLATELET FUNCTION EVALUATION BY USING A NEW POINT-OF-CARE SYSTEM AND PLATELET LIGHT-TRANSMISSION AGGREGATION IN A LARGE COHORT OF CORONARY ARTERY DISEASE PATIENTS
  - RISK OF BLEEDING IN VERY OLD ATRIAL FIBRILLATION PATIENTS ON WARFARIN: RELATIONSHIP WITH AGEING AND CHADS2 SCORE
  - CLINICAL DETERMINANTS OF PLATELET FUNCTION IN PATIENTS WITH CAD UNDERGOING CORONARY ANGIOGRAPHY AND TREATED BY DUAL ANTIPLATELET THERAPY
  - ROLE OF D-DIMER IN COMBINATION WITH F1+2, RVO AND THROMBOPHILIA IN THE RISK OF RECURRENCE OF PATIENTS WITH A FIRST VTE EPISODE AFTER OAT WITHDRAWA
  - QUALITY OF OAT AND VTE RECURRENCE
Antovic J.P. - INCREASED THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) LEVELS IN EXPERIMENTAL HUMAN ENDOTOXEMIA IS CAUSED BY BOTH INFLAMMATORY RESPONSE AND THROMBIN GENERATION
Antovic A. - OVERALL HAEMOSTASIS POTENTIAL IN PATIENTS WITH VENOUS THROMBOSIS BEFORE, DURING AND AFTER ANTICOAGULANT TREATMENT
Antovic A.M. - FIBRIN GEL POROSITY RELATES TO GLYCOSYLATED HAEMOGLOBIN IN PATIENTS WITH TYPE 1 DIABETES
  - FIBRIN GEL POROSITY: COMPARISON OF TWO LABORATORY ASSAYS
Antovic J. - PREANALYTICAL CONDITIONS INFLUENCING FLOW CYTOMETRIC DETERMINATION OF PLATELET-DERIVED MICROPARTICLES (PDMP)
  - COAGULATION ABNORMALITIES IN WOMEN WITH VERIFIED MENORRHAGIA IS IT TIME FOR INCLUSION OF COAGULATION SCREENING IN DIAGNOSTIC ALGORITHM?
Antovic J.P. - COMPARISON OF THREE DIFFERENT TAFI ASSAYS IN PATIENTS WITH ACUTE CORONARY SYNDROME
Antrobus R. - IDENTIFICATION OF NOVEL TYROSINE PHOSPHORYLATED SIGNALLING PROTEINS FOLLOWING IIb3-MEDIATED PLATELET SPREADING: INVOLVEMENT OF THE IMMUNOGLOBULIN SUPERFAMILY MEMBERS G6B-B AND G6F, AND THE NOVEL PLATELET ADAPTER DOK-3
Antunes M. - RFVIIA IN THE TREATMENT OF GLANZMANN'S THROMBASTHENIA - CASE REPORT
Appa R. - INVESTIGATION OF HUMAN RECOMBINANT FVIIA METABOLISM IN A PERFUSED RAT LIVER MODEL
Appaloop M.V. - APPLICATION OF AUTOLOGOUS RED BLOOD CELLS CONCENTRATE DERIVED FROM UMBILICAL CORD BLOOD FOR THERAPY OF ANAEMIC NEONATES
Appel I.M. - AGE-RELATED CHANGES BY ASPARAGINASE ON COAGULATION AND FIBRINOLYSIS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Appelbom H. - ENDOGENOUS THROMBIN POTENTIAL (ETP) IN PLASMA FROM PATIENTS WITH AMI DURING ANTITHROMBOTIC TREATMENT
Appendino G. - EFFECTS OF 8-PRENYLNARINGENIN, A NOVEL PHYTOESTROGEN, ON HUMAN PLATELETS
Apperley J. - ATTEMPTED ERADICATION OF HIGH RESPONDING FVIII INHIBITOR BY ALLOGENEIC BONE MARROW TRANSPLANTATION
Apperson-Hansen C. - ANTICOAGULANT RESPONSES IN PATIENTS RECEIVING LOW MOLECULAR WEIGHT HEPARIN COMPARED TO UNFRACTIONATED HEPARIN FOR TEE GUIDED CARDIOVERSION OF ATRIAL FIBRILLATION: RESULTS FROM THE ASSESSMENT OF CARDIOVERSION USING TRANSESOPHAGEAL ECHOCARDIOGRAPHY (ACUTE
Appiah Kubi K. - RESEARCH IN CELL APOPTOSIS
  - RESEARCH IN CELL APOPTOSIS
Appleby J.A. - REGULATION OF THE PLATELET PROCOAGULANT RESPONSE
  - DESIGN OF A PLATELET SUBSTITUTE UTILISING HOST FIBRINOGEN TO ENHANCE HAEMOSTASIS
Appleby N. - ONCE DAILY TINZAPARIN SODIUM (175 INTERNATIONAL UNITS PER KG) IS SAFE AND EFFECTIVE FOR ANTENATAL THROMBOPROPHYLAXIS IN HIGH RISK PREGNANCIES AND FOR TREATMENT OF ANTENATAL VENOUS THROMBOEMBOLIC EVENTS
Appleby J.A. - ACTIVATED PLATELETS INDUCE TISSUE FACTOR PATHWAY INHIBITOR IN PERIPHERAL BLOOD MONOCYTES
Aquino J.W. - FACTOR V INHIBITORS: DIVERSITY IN CLINICAL PRESENTATION
Araba F. - FONDAPARINUX IS A SAFE AND EFFECTIVE ALTERNATIVE ANTICOAGULANT IN PREGNANT WOMEN WITH INTOLERANCE TO LOW-MOLECULAR- WEIGHT HEPARINS AND HEPARINOIDS
Arachiche A. - THE RAPID PROCOAGULANT MEMBRANE SCRAMBLING INDUCED BY CALCIUM IONOPHORES IN PLATELETS AND LYMPHOCYTES IS DIFFERENT FROM THAT INDUCED BY THAPSIGARGIN IN PLATELETS: DEMONSTRATION WITH CYCLOSPORIN A
Aracil E. - DEEP VEIN THROMBOSIS AND THE RISK OF RECURRENT PULMONARY EMBOLISM
Arad A. - ANTI CD20 MONOCLONAL ANTIBODIES THERAPY FOR RESISTANT ANTIPHOSPHOLIPID SYNDROME
Arahara M. - PATHOPHYSIOLOGICAL MECHANISMS OF VASCULOPATHY IN SYSTEMIC SCLERODERMA (SSC): PLATELET ACTIVATION INDUCED BY APL IS ASSOCIATED WITH ARTERIAL THROMBOSES AND DIGITAL PITTING SCAR IN SSC PATIENTS
Arai J. - QUANTIFICATION OF BLOOD COAGULATION FACTOR XIII ANTIGEN BY LATEX IMMUNOTURBIDIMETRIC ASSAY
Araki S. - 2-AG PLAY A ROLE ON ASPIRIN RESISTANCE IN TYPE 2 DIABETES
Araujo G.S. - HEMOSTATIC CHANGES IN BRAZILIAN SPOTTED FEVER
Arber C. - PLATELET REFRACTORINESS DUE TO ANTI-HLA AND ANTI-HPA-5A ALLOANTIBODIES: CLINICAL MANAGEMENT DURING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Arbring K. - SNAPSHOT OF WARFARIN TREATMENT IN DIFFERENT SETTINGS: A CROSS SECTION STUDY IN SWEDISH PRIMARY HEALTH CARE CENTERS VS ANTICOAGULATION CLINICS
Arcari A. - ASSOCIATION OF C-REACTIVE PROTEIN AND WHITE BLOOD CELL COUNT WITH PHYSICAL ACTIVITY IN HEALTHY SUBJECTS
  - ASSOCIATION OF C-REACTIVE PROTEIN AND ALCOHOL INTAKE IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION
  - ASSOCIATION OF C-REACTIVE PROTEIN, OBESITY AND METABOLIC SYNDROME IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION
  - FIBRIN D-DIMERS IS ASSOCIATED WITH PREVALENT CARDIOVASCULAR EVENTS IN THE MOLI-SANI STUDY
Archararit N. - NORMALIZED PHOSPHATIDYLSERINE EXPRESSION ON RED BLOOD CELLS IN CHILDREN WITH SEVERE THALASSEMIA DISEASE AFTER STEM CELL TRANSPLANTATION
Arcozzi C. - TISSUE FACTOR AND COAGULATION FACTOR VII LEVELS DURING ACUTE MYOCARDIAL INFARCTION CONTRIBUTE TO PREDICT MORTALITY AND RE-INFARCTION
Ardeshiri R. - FACTOR XI DEFICIENCY IN SOUTHERN IRAN AND REVIEW OF LITERATURE
Aref S. - CLINICAL SIGNIFICANCE OF MEAN PLATELETS VOLUME IN CORONARY ARTERY DISEASE
  - CLINICAL SIGNIFICANCE OF MEAN PLATELETS VOLUME IN CORONARY ARTERY DISEASE
Arellano A.R. - FACTOR IX MALM IS ASSOCIATED WITH VENOUS THROMBOSIS
  - GENETIC VARIATION IN THE CYP4V2 GENE IS ASSOCIATED WITH VENOUS THROMBOSIS
  - A FEASIBILITY STUDY OF RISK STRATIFICATION FOR RECURRENT VENOUS THROMBOSIS BY MULTIPLE SNP ANALYSIS
Arenaz I. - PARACRINE UP-REGULATION OF MONOCYTE CYCLOOXYGENASE-2 BY PLATELETS: ROLE OF TGF-BETA1
  - CYCLOOXYGENASE-2 IS CRITICAL FOR HYDROGEN PEROXIDE-MEDIATED WOUND REPAIR IN HUMAN ENDOTHELIAL CELLS
Arepally G.M. - DEVELOPING ANTIDOTE CONTROLLED ANTIPLATELET THERAPIES BY TARGETING THE VWF - GP IB-IX-V INTERACTION
  - TISSUE FACTOR AROUND DERMAL VESSELS HAS BOUND FACTOR VII IN THE ABSENCE OF INJURY
Arghirescu S. - HEMOSTATIC EXPRESSION OF IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDREN
Arias-Salgado E. - CORRELATION BETWEEN SCD40L LEVELS AND METALLOPROTEINASE EXPRESSION WITH THE PLATELET FUNCTIONAL RESPONSE IN IMMUNOLOGICAL DISEASES
Arias-Salgado E.G. - INTEGRIN-LINKED KINASE (ILK) IN PLATELET ALPHAIIB-BETA3 SIGNALING AND ARTERIAL THROMBOSIS
Arici V. - EFFICACY OF FONDAPARINUX IN HEPARIN-INDUCED THROMBOCYTOPENIA WITH OR WITHOUT THROMBOEMBOLIC COMPLICATIONS
Ariens R.A.S. - RECOMBINANT BBETA-LYS448 IS ASSOCIATED WITH SIGNIFICANT CHANGES IN FIBRIN STRUCTURE AND CLOT RIGIDITY
  - MULTIPLE SITES OF FXIIIA ARE INVOLVED IN THE BINDING INTERACTION TO THE ALPHA CHAIN OF FIBRINOGEN
  - THE LOCALISATION OF A NOVEL FACTOR XIIIB BINDING SITE ON THE ALPHA CHAIN OF FIBRINOGEN AND ITS ROLE IN FXIII DISSOCIATION
Ariga T. - A NOVEL FIBRINOLYTIC FACTOR ADIPOMIN REGULATES ADIPOSITY
  - A ROLE OF SURFACE-BOUND PLASMINOGEN IN THE LIVER REGENERATION IN RAT
Arikat M. - CHARACTERISATION OF THE MOLECULAR GENETIC DEFECTS UNDERLYING GLANZMANN'S THROMBASTHENIA IN JORDANIAN FAMILIES
Arinami T. - CLINICAL PROFILE AND MOLECULAR BASIS OF GLANZMANN'S THROMBASTHENIA [GT] IN THE SULTANATE OF OMAN
Arjmandi Rafsanjani K. - CLINICAL FEATURES AND TREATMENT OUTCOMES OF INFANTS WITH IMMUNE THROMBOCYTOPENIC PURPURA
Arkin C.F. - RESULT DISCREPANCIES BETWEEN TWO LUPUS ANTICOAGULANT (LA) METHODS
Armstrong A.E. - ACQUIRED HEMOPHILIA: ANALYSIS OF THE HEMOPHILIA AND THROMBOSIS RESEARCH SOCIETY (HTRS) REGISTRY
Armstrong E. - SIGNIFICANT DISTINCTION BETWEEN PLASMA- AND PLATELET-DEPENDENT COAGULATION ACTIVITY IN HEMOPHILIA A PATIENTS
Armstrong A. - EPIDEMIOLOGY OF THROMBOEMBOLISM (TE) IN CHILDREN WITH CANCER
Arnalsteen L. - ANTITHROMBIN REDUCES COAGULATION AND INFLAMMATION IN A PIG MODEL OF ISLET TRANSPLANTATION
Arnaud B. - MONOCYTES DOWN-REGULATE INITIAL PHASE OF COLLAGEN-INDUCED PLATELET ACTIVATION
Arnaud L. - IMMUNO-MAGNETIC ENRICHMENT FOLLOWED BY MULTI-PARAMETER FLOW CYTOMETRY: A NEW APPROACH TO COUNT CIRCULATING ENDOTHELIAL CELLS
Arndt B. - AN IN VIVO RISK/BENEFIT COMPARISON OF THE EFFECTS OF RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR WITH THROMBIN INHIBITORS, WARFARIN AND CLOPIDOGREL
Arnesen H. - ENDOGENOUS THROMBIN POTENTIAL (ETP) IN PLASMA FROM PATIENTS WITH AMI DURING ANTITHROMBOTIC TREATMENT
  - BENEFICIAL EFFECT OF 1-YEAR OPTIMAL MEDICAL TREATMENT, INDEPENDENT OF ADDITIONAL PTA, ON INFLAMMATION IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE (PAD)
  - PLASMINOGEN ACTIVATOR INHIBITOR-1 ACTIVITY PREDICTS RHYTHM OUTCOME AFTER ELECTRICAL CARDIOVERSION FOR ATRIAL FIBRILLATION
Arning M. - ELTROMBOPAG, AN ORAL, NON-PEPTIDE PLATELET GROWTH FACTOR, INCREASES PLATELET COUNTS AND DECREASES BLEEDING IN PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA IN A PHASE III STUDY
Arnold E. - HIGH PREVALENCE OF IRON DEFICIENCY AMONG PATIENTS REFERRED FOR EVALUATION OF A BLEEDING DISORDER
  - GLOBAL ASSAYS OF PLATELET FUNCTION IN DIAGNOSTIC TESTING
Arnott S. - USE OF RECOMBINANT ACTIVATED FACTOR VIIA (RFVIIA) IN MASSIVE HAEMORRHAGE
Arnould B. - MULTINATIONAL DEVELOPMENT OF A QUESTIONNAIRE ASSESSING PATIENT SATISFACTION WITH ANTI-COAGULANT TREATMENT
Arocas V. - PROTEASE NEXIN-1 AND THROMBOMODULIN FORM COMPLEXES WITH A HIGHLY POTENT ANTI-THROMBIN ACTIVITY
Aronis S. - MORE THAN ONE EPISODES IN CHILDHOOD ITP WITH A MEDIASTINUM OF MONTHS OR YEARS. A 30 YEARS RETROSPECTIVE ANALYSIS
Aronis-Vournas S. - DATABASE ON RARE BLEEDING DISORDER (RBDS): PHENOTYPE AND GENOTYPE ANALYSIS ON 400 AFFECTED PATIENTS
Arpaia G. - D-DIMER AS PREDICTIVE FACTOR FOR VENOUS THROMBOEMBOLISM IN CANCER PATIENTS BEFORE CHEMOTHERAPY
Arpin M. - VASP PHOSPHORYLATION ANALYSIS PRIOR TO PERCUTANEOUS CORONARY INTERVENTION FOR EXCLUSION OF POST-PROCEDURAL MAJOR ADVERSE CARDIOVASCULAR EVENTS
Arquati M. - E-SELECTIN AND TFPI ARE ASSOCIATED WITH CAROTID INTIMA-MEDIA THICKNESS IN STABLE CORONARY PATIENTS: THE BASELINE FINDINGS OF THE MIAMI STUDY
Arrabal S. - CONTRIBUTION OF CHROMATOGRAPHY STEPS IN PRION REMOVAL IN PLASMA-DERIVED PRODUCT MANUFACTURING
  - EFFICIENT PRION REMOVAL DURING THE MANUFACTURING PROCESS OF BETAFACT, A HIGH-PURITY PLASMA DERIVED FACTOR IX
Arruda V.R. - SUCCESSFUL LONG TERM EXPRESSION OF FVIII AFTER GENE DELIVERY OF NOVEL ADENO-ASSOCIATED VIRAL VECTOR SEROTYPES IN HEMOPHILIA A DOGS
  - IN VIVO EFFECTS OF MURINE AND HUMAN APC
  - THE ROLE OF FACTOR VIII IN THE DEVELOPMENT OF ATHEROSCLEROTIC LESIONS IN MURINE MODELS
Arruda V. - PROTEASE-ACTIVATED RECEPTOR 2 (PAR-2) A NOVEL TARGET TO PREVENT FIX INHIBITOR FORMATION
Arruda V.R. - NOVEL MODELS OF THROMBOPHILIA RESULT IN SPONTANEOUS PERIPHERAL THROMBOSIS AND PREGNANCY-RELATED COMPLICATIONS
  - DUAL GENE TRANSFER OF FGF-2 AND PDGF-BB USING PLASMID DNA PROMOTES EFFECTIVE ANGIOGENESIS AND ARTERIOGENESIS IN A RODENT MODEL OF HINDLIMB ISCHEMIA
Arsène S. - ASSOCIATION BETWEEN THE HOMOZYGOUS STATUS FOR THE 807T ALLELE OF ITGA2 AND RETINAL ARTERY OCCLUSION
Arslan N. - USAGE OF FACTOR VIIA IN A CASE OF HEMORRHAGIC CYSTITIS DEVELOPED SECONDARY TO CHEMOTHERAPY
Arthur J.F. - RAPID LIGAND-INDUCED DIMERIZATION OF PLATELET GLYCOPROTEIN VI
Artoni A. - GENETIC CHARACTERIZATION OF PATIENTS WITH BERNARD-SOULIER SYNDROME AND THEIR RELATIVES FROM SOUTHERN IRAN
  - PHENOTYPIC ANALYSIS OF THREE MUTATIONS CAUSING GLANZMANN THROMBASTHENIA
Arveiler B. - PLATELET ABNORMALITIES IN PATIENTS WITH CONSTITUTIONAL DEFECTS IN FILAMIN A
Arya R. - USE OF RECOMBINANT ACTIVATED FACTOR VIIA (RFVIIA) IN MASSIVE HAEMORRHAGE
  - VENOUS THROMBOSIS (VTE) HAS AN ADVERSE IMPACT ON THE SURVIVAL IN PATIENTS WITH MALIGNANCY
Aryuchai K. - FIBRINOGEN THR312ALA BUT NOT FXIIIA VAL34LEU AND FXIIIB HIS95ARG POLYMORPHISMS ASSOCIATED WITH THAI DEEP VENOUS THROMBOSIS
Aryurachai K. - NORMALIZED PHOSPHATIDYLSERINE EXPRESSION ON RED BLOOD CELLS IN CHILDREN WITH SEVERE THALASSEMIA DISEASE AFTER STEM CELL TRANSPLANTATION
Arza B. - PERFORMANCE OF A NEW TURBIDIMETRIC D-DIMER ASSAY ADAPTED TO AUTOMATED COAGULOMETERS
Arzanian M. - CHILDHOOD GERM CELL TUMOR PRECEDING BY CHRONIC LONGSTANDING DIC
Asada Y. - PLATELET IS AN IMPORTANT FACTOR IN VENOUS THROMBOEMBOLISM: INTERACTION OF VON WILLEBRAND FACTOR AND PLATELET GPIB PROMOTES VENOUS THROMBUS GROWTH
  - ADAMTS-13 WITHIN THROMBUS DOWN-REGULATES THROMBUS FORMATION UNDER FLOW CONDITIONS
  - FUNCTIONAL REGULATION OF VON WILLEBRAND FACTOR ON THE FORMATION OF PLATELET THROMBI UNDER BLOOD FLOW CONDITION BY ITS SPECIFIC CLEAVING PROTEASE OF ADAMTS13
  - MECHANISMS OF THROMBUS FORMATION DIFFER BETWEEN ATHEROSCLEROTIC AND NORMAL ARTERIES IN HYPERCHOLESTEROLEMIC RABBITS
Asadollahi S. - THE CLINICAL RESULTS OF P32 RADIOSYNOVECTOMY IN HEMOPHILIC PATIENTS WITH CHRONIC SYNOVITIS
Asai F. - COMPARISON OF ANTIPLATELET AND ANTITHROMBOTIC EFFECTS OF PRASUGREL AND AZD6140
  - FLOW CYTOMETRIC ANALYSIS OF VASP PHOSPHORYLATION IN PLATELETS TREATED WITH THE ACTIVE METABOLITE OF PRASUGREL, A P2Y12 ADP RECEPTOR ANTAGONIST
Asakura H. - PATHOPHYSIOLOGICAL MECHANISMS OF VASCULOPATHY IN SYSTEMIC SCLERODERMA (SSC): PLATELET ACTIVATION INDUCED BY APL IS ASSOCIATED WITH ARTERIAL THROMBOSES AND DIGITAL PITTING SCAR IN SSC PATIENTS
  - CLINICAL SIGNIFICANCE OF PLATELET-DERIVED MICROPARTICLE (PDMP) IN APS: PLASMA LEVELS OF PDMP WERE SIGNIFICANTLY ELEVATED IN APS PATIENTS WITH ARTERIAL THROMBOSES
Asanuma K. - REGULATION OF BREAST CANCER CELL GROWTH, METASTASIS AND ANGIOGENESIS BY PROTEIN C INHIBITOR
Asbel N.R. - A PHASE II DOUBLE-BLIND PLACEBO-CONTROLLED PARALLEL-GROUP RANDOMIZED STUDY OF EXTENDED PROPHYLAXIS WITH ODIPARCIL FOLLOWING TOTAL HIP ARTHROPLASTY (THA)
Ascani A. - SOCIAL COSTS OF ANTICOAGULANT TREATMENT FOR ATRIAL FIBRILLATION
Asencio J. - ANKLE REPLACEMENT IN SEVERE BLEEDING DISORDERS: RETROSPECTIVE STUDY ON 17 CASES
Ashby D. - LACK OF EFFECT OF INFLUENZA IMMUNISATION ON ANTICOAGULANT CONTROL IN PATIENTS ON LONG-TERM WARFARIN
Asher I. - THROMBOPHILIA IS ASSOCIATED WITH HEPARIN THROMBOPROPHYLAXIS FAILURE IN PATIENTS WITH ACUTE TRAUMATIC SPINAL CORD INJURY
Ashman L.K. - IMPAIRED 'OUTSIDE-IN' INTEGRIN ALPHAIIBBETA3 SIGNALING AND THROMBUS STABILITY IN CD151 AND TSSC6-DEFICIENT MICE
Ashouri E. - GENETIC CHARACTERIZATION OF PATIENTS WITH BERNARD-SOULIER SYNDROME AND THEIR RELATIVES FROM SOUTHERN IRAN
Ashrani A.A. - RISK FACTORS FOR VENOUS THROMBOEMBOLISM (VTE) AMONG ACTIVE CANCER PATIENTS: A POPULATION-BASED CASE-CONTROL STUDY
  - IMPACT OF VENOUS THROMBOEMBOLISM, VENOUS STASIS SYNDROME, VENOUS OUTFLOW OBSTRUCTION AND VENOUS VALVULAR INCOMPETENCE ON QUALITY OF LIFE AND ACTIVITIES OF DAILY LIVING: A POPULATION-BASED CASE-CONTROL STUDY
Asmelash G. - THE TYPE OF MANIFESTATION OF THE ANTIPHOSPHOLIPID SYNDROME IN RELATION TO THE AGE OF THE PATIENTS
Asmis L.M. - COMPARISON OF THREE METHODOLOGIES TO ASSAY D-DIMER LEVELS IN SURGICAL PATIENTS: D DIMER ON MINIVIDAS VS. TINA-QUANT ON MODULAR P VS. TINA-QUANT ON BEHRING COAGULATION SYSTEM - A CALL FOR STANDARDISATION IN D-DIMER TESTING
Asmis L. - DISTINCTIVE THROMBOELASTOGRAPHIC FINDINGS (TEG-PM IN RESPONSE TO ADP) IN A FAMILY WITH BERNARD SOULIER SYNDROME
Aspelin T. - CARDIAC tPA RELEASE DURING SYMPATHETIC NERVE STIMULATION IN PIGS DECREASES BY REPEATED STIMULATIONS
Asproudis I. - A HIGH NORMAL VALUE OF PLASMA PROTEIN Z IS AN UNCOMMON FINDING IN NON-ARTERITIC ISCHEMIC OPTIC NEUROPATHY (N-AION) PATIENTS
Assadian A. - LOW HDL CHOLESTEROL AND LOW HDL TRIGLCERIDES IN PATIENTS WITH SYMPTOMATIC AND ASYMPTOMATIC HIGH GRADE INTERNAL CAROTID ARTERY STENOSIS
Assanelli D. - TISSUE FACTOR GENE TAG-SNPS AND HAPLOTYPES AND THE RISK OF MYOCARDIAL INFARCTION
Asselta R. - DATABASE ON RARE BLEEDING DISORDER (RBDS): PHENOTYPE AND GENOTYPE ANALYSIS ON 400 AFFECTED PATIENTS
  - MISSENSE MUTATIONS IN THE COILED-COIL REGION OF FIBRINOGEN AALPHA CHAIN CAUSE FIBRINOGEN DEFICIENCY BY IMPAIRING DIMERIZATION OF TRIMERIC INTERMEDIATES
  - A NOVEL MECHANISM FOR CONGENITAL AFIBRINOGENEMIA BASED ON PSEUDOEXON ACTIVATION IN THE FIBRINOGEN GAMMA-CHAIN GENE
  - CHARACTERIZATION OF THE F11 ALTERNATIVE SPLICING PATTERN: IDENTIFICATION OF A NOVEL COAGULATION FXI ISOFORM
  - SIMULTANEOUS GENOTYPING OF FXI TYPE II AND TYPE III MUTATIONS BY MULTIPLEX REAL-TIME PCR IN HEALTHY ITALIANS AND IN FXI-DEFICIENT PATIENTS
  - ALTERNATIVE SPLICING AND NONSENSE-MEDIATED DECAY IN THE F5 GENE
Assunção E. - FACTOR V INHIBITORS: DIVERSITY IN CLINICAL PRESENTATION
Aster R.H. - MONOCLONAL ANTIBODIES THAT MIMIC ANTIBODIES FOUND IN PATIENTS WITH DRUG (QUININE(QN))-INDUCED IMMUNE THROMBOCYTOPENIA (DITP): IMPLICATIONS FOR THE PATHOGENESIS OF DITP
Aster R. - HUMAN PLATELETS CIRCULATING IN MICE: APPLICATIONS FOR INTERROGATING PLATELET FUNCTION AND SURVIVAL, THE EFFICACY OF ANTI-PLATELET THERAPEUTICS, AND THE MOLECULAR BASIS OF PLATELET IMMUNOLOGICAL DISORDERS
Aster R.H. - RARE ANTIGENS IN NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
Astermark J. - GENETIC AND ENVIRONMENTAL RISK FACTORS FOR FVIII INHIBITOR DEVELOPMENT
  - BREAKTHROUGH BLEEDING IN SEVERE HAEMOPHILIA A. DOES THE FVIII TROUGH LEVEL MATTER?
  - BLEEDING PATTERNS ON PROPHYLAXIS FOR SEVERE HAEMOPHILIA: WEEK DAY AND SEASONAL INFLUENCE
  - THE CAPACITY TO GENERATE THROMBIN IN FACTOR VIII INHIBITOR PLASMAS DIFFERS AMONG COMMERCIAL CONCENTRATES AND IS ASSOCIATED WITH VON WILLEBRAND FACTOR CONTENT. IS THIS OF IMPORTANCE FOR ITI SUCCESS?
Asti D. - INTERFERENCE OF FACTOR V LEIDEN ON PROTEIN S ACTIVITY. EVALUATION OF A NEW PROTHROMBIN TIME-BASED ASSAY
Ataiei Z. - THE PROTECTIVE EFFECT OF FXIII VAL34LEU POLYMORPHISM AGAINST VENOUS THROMBOSIS IN IRANIAN PATIENTS
Atallah A. - EFFECT OF THE IMPLEMENTATION OF A VENOUS THROMBOEMBOLISM PROPHYLAXIS GUIDELINE IN THE MANAGEMENT OF SURGICAL AND ORTHOPEDIC PATIENTS IN A PRIVATE TERTIARY HOSPITAL
Atamonov V.A. - D-DIMER IN PATIENTS WITH ACUTE LEUKEMIA AFTER TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS
Ataullakhanov F. - WALL CLOT GROWTH IN PLASMA: EFFECT OF HIGH DOSES RECOMBINANT FVIIA
Ataullakhanov F.I. - THRESHOLD BEHAVIOR OF THE BLOOD CLOTTING SYSTEM ACTIVATED BY THE TISSUE FACTOR
  - BLOOD FLOW SUPPRESSES FEEDBACK ACTIVATION OF EXTRINSIC TENASE BY FACTOR XA AND PREVENTS CLOTTING
  - FORMATION OF SUBPOPULATIONS WITH DIFFERENT PHOSPHATIDYLSERINE EXPRESSION DURING THROMBIN-STIMULATED PLATELET ACTIVATION IS CONTROLLED BY ALPHA-GRANULE ADP SECRETION
Athale U. - EPIDEMIOLOGY OF THROMBOEMBOLISM (TE) IN CHILDREN WITH CANCER
Athanasiou M. - HAEMOSTATIC PROFILE OF FULL TERM HEALTHY SMALL FOR GESTATIONAL AGE (SGA) NEONATES
Athanassiadou F. - HAEMOSTATIC PROFILE OF FULL TERM HEALTHY SMALL FOR GESTATIONAL AGE (SGA) NEONATES
Atkinson B.T. - INACTIVE TISSUE FACTOR CONTAINING EXPOSED THIOLS RESIDES ON THE SURFACE OF UNSTIMULATED ENDOTHELIAL CELLS
Atsumi G. - CIRCADIAN VARIATIONS IN COAGULATION AND FIBRINOLYTIC FACTORS AMONG FOUR STRAINS OF MICE
Atsumi T. - THE P38 MITOGEN-ACTIVATE PROTEIN KINASE MAPK) PATHWAY MEDIATES THE INDUCTION OF TISSUE FACTOR EXPRESSION BY PHOSPHATIDYLSERINE-DEPENDENT ANTIPROTHROMBIN ANTIBODIES WITH LUPUS ANTICOAGULANT ACTIVITY
  - DIAGNOSTIC SIGNIFICANCE OF TESTING ANTI-BETA2-GLYCOPROTEIN I ANTIBODIES FOR THE ANTIPHOSPHOLIPID SYNDROME
Atta N. - RISK FACTORS AND OUTCOME OF THROMBOEMBOLIC EVENTS IN CHILDREN UNDERGOING CARDIAC SURGERY
Attanasio M. - QUALITY OF OAT AND VTE RECURRENCE
  - GENETIC ANALYSIS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS-GAMMA (PPARG) PROMOTERS: ACUTE CORONARY SYNDROME PATIENTS VERSUS CONTROLS
  - PLATELET FUNCTION EVALUATION BY USING A NEW POINT-OF-CARE SYSTEM AND PLATELET LIGHT-TRANSMISSION AGGREGATION IN A LARGE COHORT OF CORONARY ARTERY DISEASE PATIENTS
  - MUTATION SCREENING ANALYSIS OF TGFBR1 GENE IN PATIENTS WITH MARFAN SYNDROME
  - HOMOCYSTINURIA AND CARDIOVASCULAR MANIFESTATIONS: 5 ITALIAN CASES
Attema M.E. - PERIOPERATIVE PROPHYLACTIC DOSING OF TINZAPARIN IN MORBID OBESE PATIENTS
Atwal H. - PEGYLATION PROTECTS FACTOR VIII FROM THE INHIBITION OF ANTIBODY INHIBITORS
Aubry M.L. - SEVERE FACTOR VII DEFICIENCY DUE TO MUTATIONS IN THE FACTOR VII GENE PROMOTER
Auerswald G. - EFFICACY AND SAFETY OF A HIGHLY PURIFIED FACTOR IX CONCENTRATE IN PAEDIATRIC PATIENTS WITH HAEMOPHILIA B - RESULTS OF A CLINICAL TRIAL AND A POST MARKETING SURVEILLANCE STUDY
  - THE CHALLENGE OF PRAEOPERATIVE INVESTIGATION OF HEREDITARY AND ACQUIRED COAGULATION DISORDERS IN CHILDREN AND ADOLESCENTS
  - INHIBITOR OF FVII IN CONGENITAL SEVERE FACTOR VII DEFICIENCY
  - GYNAECOLOGICAL BLEEDING IN CONGENITAL FACTOR VII DEFICIENCY
  - PROSPECTIVE POST LICENSURE SURVEILLANCE OF EFFICACY AND TOLERABILITY OF A HIGH PURITY, DOUBLE VIRUS INACTIVATED VWF/FVIII CONCENTRATE IN THE TREATMENT OF VON WILLEBRAND'S DISEASE
  - CLINICAL EFFICACY AND SAFETY OF A NOVEL HIGH-PURITY, DOUBLE VIRUS-INACTIVATED VWF/FVIII-CONCENTRATE IN THE TREATMENT OF VON WILLEBRAND DISEASE AN UPDATE ON THE CLINICAL PROGRAMME
  - PHYSICAL EXAMINATION IN PATIENTS WITH SEVERE HEMOPHILIA UNDER PROPHYLACTIC TREATMENT - EFFICACY OF AN EARLY LONG-TERM PROPHYLAXIS?
Auger J.M. - A GADS-INDEPENDENT PATHWAY OF PLCGAMMA2 REGULATION DOWNSTREAM OF THE COLLAGEN RECEPTOR, GPVI
  - CONTRIBUTIONS OF COLLAGEN AND GLYCOPROTEIN VI SIGNALLING IN THE INTRINSIC PATHWAY OF COAGULATION
  - COLLAGEN PROMOTES SUSTAINED GPVI SIGNALING IN PLATELETS AND CELL LINES
  - DYNAMIC SIGNALLING EVENTS AND FIBRIN-INDEPENDENT RETRACTION CONTRIBUTE TO THROMBUS STABILITY UNDER SHEAR
Aujesky D. - MULTI-DETECTOR SPIRAL COMPUTED TOMOGRAPHY ALONE VERSUS COMBINED WITH LOWER LIMB COMPRESSION ULTRASONOGRAPHY IN OUTPATIENTS SUSPECTED OF PULMONARY EMBOLISM: A RANDOMISED NON-INFERIORITY TRIAL
Aukrust P. - ELEVATED SERUM LEVELS OF LIGHT IN PULMONARY ARTERIAL HYPERTENSION-POTENTIAL INVOLVEMENT IN THROMBUS FORMATION
Aumont M. - D-DIMER AND PROGNOSIS IN PATIENTS WITH CHRONIC ATRIAL FIBRILLATION
Austin S.K. - DECREASED ADAMTS13 AND ANTI-ADAMTS13 IN THE ANTIPHOSPHOLIPID SYNDROME (APS)
  - SUCCESSFUL MANAGEMENT OF LATE OBSTETRIC COMPLICATIONS IN THE ANTIPHOSPHOLIPID SYNDROME
Austin S. - COMBINING 4T'S PRE-TEST CLINICAL SCORE AND ID-PAGIA HEPARIN/PF4 TEST TO EXCLUDE HEPARIN INDUCED THROMBOCYTOPENIA (HIT)
Austin H. - THE ALPHA FIBRINOGEN THR312ALA POLYMORPHISM AND VENOUS THROMBOEMBOLISM IN AMERICAN CAUCASIANS AND AFRICAN AMERICANS: THE GATE STUDY
  - POLYMORPHISMS IN THE 3'-END OF THE FIBRINOGEN GAMMA GENE AND RISK OF VENOUS THROMBOEMBOLISM IN THE AFRICAN-AMERICAN AND CAUCASIAN POPULATION
Austin S.K. - MANAGING PERI-DELIVERY ANTICOAGULATION IN WOMEN ON THERAPEUTIC DOSE LOW-MOLECULAR WEIGHT HEPARIN: A ROLE FOR UNFRACTIONATED HEPARIN
Austin H. - PULMONARY EMBOLISM, OBESITY, DIABETES, AND HYPERTENSION AMONG AMERICAN CAUCASIANS IN THE GATE STUDY
  - VENOUS THROMBOEMBOLISM, FACTOR V LEIDEN, AND PROTHROMBIN 20210 AMONG AMERICAN CAUCASIANS IN THE GATE STUDY
Auteri A. - INFLUENCE OF LECTIN-LIKE OX-LDL RECEPTOR-1 (LOX-1) AND NITRIC OXIDE SINTHASE (NOS) POLYMORPHISMS IN ATORVASTATIN ANTITHROMBOTIC ACTION AND CARDIOVASCULAR EVENTS RATE
Authi K.S. - AKT ACTIVATION BY PHOSPHAPHATIDYLINOSITOL-3,4,5-TRISPHOSPHATE IN HUMAN PLATELETS IS DEPENDENT ON EXTRACELLULAR CA2+
Auton M. - STRUCTURAL AND THERMODYNAMIC EFFECTS OF TYPE 2M AND TYPE 2B VWD MUTATIONS IN THE A1 DOMAIN OF VWF
Avery M. - EPOTHILONE B INHIBITS NEOINTIMAL FORMATION AFTER RAT CAROTID INJURY THROUGH THE REGULATION OF CELL CYCLE-RELATED PROTEINS
Avigliano L. - MODULATION OF PLATELET FUNCTION BY THE ENDOCANNABINOID 2-ARACHIDONOYLGLYCEROL
Avilov O.E. - BLOOD FLOW SUPPRESSES FEEDBACK ACTIVATION OF EXTRINSIC TENASE BY FACTOR XA AND PREVENTS CLOTTING
Awidi A.A. - CHARACTERISATION OF THE MOLECULAR GENETIC DEFECTS UNDERLYING GLANZMANN'S THROMBASTHENIA IN JORDANIAN FAMILIES
Awosile F.S. - DEFINING THE STRUCTURE OF MEMBRANE-BOUND HUMAN BLOOD COAGULATION FACTOR VA
Ay C. - SOLUBLE P-SELECTIN AND THE RISK OF THROMBOTIC EVENTS IN PATIENTS WITH A LUPUS ANTICOAGULANT IN A PROSPECTIVE COHORT STUDY
  - P-SELECTIN (P-SEL) GENE HAPLOTYPES MODULATE SOLUBLE (S) P-SEL LEVELS AND INCREASE THE RISK OF VENOUS THROMBOEMBOLISM (VTE)
  - ANGIOTENSIN-CONVERTING ENZYME (ACE) INSERTION/DELETION (I/D) POLYMORPHISM AND SERUM LEVELS OF ACE IN VENOUS THROMBOEMBOLISM (VTE)
  - A HIGH PLATELET COUNT INDEPENDENTLY PREDICTS VENOUS THROMBOEMBOLISM IN CANCER PATIENTS
Ayata M. - INCIDENCE OF PULMONARY THROMBOEMBOLISM IN AUTOPSY CASES IN A JAPANESE GENERAL HOSPITAL
Aydogan G. - FX DEFICIENCY: CHARACTERISTICS AND TREATMENT OUTCOME OF SEVEN CASES
  - EVALUATION OF OUR CASES WITH GLANZMANN THROMBASTHENIA
  - RADIOSYNOVECTOMY WITH YTRIUM-90 AND RHENIUM-186 IN HEMOPHILIC ARTHROPATY
  - THE RESULTS OF OUR FEBRILE NEUTROPENIA MANAGEMENT REPORTS FOR THREE YEARS
Aydogdu S. - RADIOISOTOPE SYNOVECTOMY WITH RHENIUM 186 FOR TREATMENT OF HEMOPHILIC SYNOVITIS
Aygören-Pürsün E. - IGE SPECIFIC FOR HUMAN FVIII FROM A PATIENT WITH HEMOPHILIA A BINDS TO THE C2 DOMAIN AND INHIBITS FVIII FUNCTION
Aykan S. - ACTIVATED PROTEIN C ATTENUATES LIPOPOLYSACCHARIDE-INDUCED ACTIVATION OF CELL DEATH AND TUMOUR NECROSIS FACTOR-ALPHA PRODUCTION IN MURINE MICROGIAL CELLS
Ayob Y. - IS TODAY'S THROMBOPHILIA PROFILE ADEQUATE IN IDENTIFYING A POSSIBLE CAUSE FOR RECURRENT FETAL LOSS IN WOMEN?
  - ACQUIRED VON WILLEBRAND DISEASE IN A PATIENT WITH SYSTEMIC LUPUE ERYTHEMATOSUS
Ayprasert N. - INTRACRANIAL AND SPINAL HEMORRHAGE IN ADULT HEMOPHILIA A IN SIRIRAJ HOSPITAL, THAILAND
Aytac S. - RISK FACTORS AND OUTCOME OF PEDIATRIC THROMBOTIC EPISODES IN A SINGLE CENTER
Ayuso M.S. - INTEGRIN-LINKED KINASE (ILK) IN PLATELET ALPHAIIB-BETA3 SIGNALING AND ARTERIAL THROMBOSIS
Azarafrooz F. - RELATIVE ANTICOAGULANT AND ANTITHROMBOTIC EFFECTS OF HEPARIN AND LOW MOLECULAR WEIGHT HEPARINS IN HUMAN AND FELINE BLOOD PLASMA. POTENTIAL THERAPEUTIC IMPLICATIONS
Azari B.M. - THE F11 RECEPTOR (F11R, JAM-A) IN ATHEROTHROMBOSIS: OVEREXPRESSION OF F11R IN ATHEROSCLEROTIC PLAQUES
Azarkeivan A. - THROMBOTIC EVENTS IN PATIENTS WITH ELEVATED FVIII LEVEL
Azarkeyvan A. - HIGH PREVALENCE OF ELEVATED FACTOR VIII IN IRANIAN PATIENT WITH IDIOPATHIC VENOUS THROMBOEMBOLISM
Azarm T. - HELICOBACTER PYLORI ERADICATION CAN INDUCE PLATELET RECOVERY IN CHRONIC REFRACTORY IDIOPATHIC THROMBOCYTOPENIC PURPURA
Azarova O.Y. - GENETIC POLYMORPHISM R353Q OF FACTOR VII HAS PROTECTIVE EFFECT IN THREATENED MISCARRIAGE
Azizi M. - LACK OF ENDOTHELIAL DYSFUNCTION IN THROMBOANGIITIS OBLITERANS
  - THE ABCB1 (MDR1) C3435T POLYMORPHISM DOES NOT INFLUENCE PHARMACODYNAMIC RESPONSE TO CLOPIDOGREL IN HEALTHY SUBJECTS
Aznar J. - ATS-13 ACTIVITY AS A COMMON MARKER OF THE ENDOTHELIAL DYSFUNCTION DEVELOPING IN THROMBOTIC MICROANGIOPATHIES OF DIFFERENT ORIGIN
  - IDENTIFICATION OF DELETIONS IN WOMEN WITH FAMILY ANTECEDENTS OF SEVERE HAEMOPHILIA B BY MULTIPLE LIGATION PROBE AMPLIFICATION METHOD. COMPARISON WITH QUANTITATIVE REAL-TIME ASSAY
  - CLINICAL, GENETIC, FUNCTIONAL AND CONFORMATIONAL HETEROGENEITY OF CONGENITAL ANTITHROMBIN DEFICIENCY. RESULTS FROM 27 UNRELATED CASES
Aznar J.A. - INFLUENCE OF ADDING 4% BSA IN THE BETHESDA ASSAY FOR FACTOR VIII INHIBITOR QUANTIFICATION
Azzaro M. - THE THERAPEUTICAL STRATEGIES ARE EFFECTIVE TO PREVENT THE RECURRENT ABORTIONS, REPEATED FETAL LOSS OR THE INTRAUTERINE FETAL GROWTH RETARDATION IN WOMEN WITH COAGULATION ABNORMALITIES AND/OR GENETIC THROMBOPHILIC MUTATIONS
  - PLASMA COAGULATION TESTS AND GENETIC THROMBOPHILIC MUTATION STUDIES ARE MANDATORY FOR PREVENTING THE IDIOPATHIC RECURRENT ABORTIONS OR REPEATED FETAL LOSS IN HEALTHY WOMEN